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ABSTRACT 
 
In response to environmental cues, neural circuits are maintained and rewired by growth 
cone dynamics, which are regulated by cytoskeleton reorganization and focal adhesion dynamics. 
Src and focal adhesion kinase (FAK) are key signaling molecules involved in these processes 
during growth cone dynamics and cell migration, and furthermore the progression of diseases 
such as cancer. Upon various chemical and mechanical environmental factors, Src and FAK can 
be localized and activated at plasma membrane, which contains different microdomains called 
lipid rafts. In this thesis, specific Src/FAK biosensors based on fluorescence resonance energy 
transfer (FRET) were developed and further targeted to subcompartments of plasma membrane 
to visualize local Src/FAK signaling events in live cells with high spatiotemporal resolution.  
Utilizing the subcellular-targeted Src biosensors, I found two distinct Src populations at 
different microdomains of plasma membrane. In response to chemical stimulations, the 
activation of Src population at lipid rafts was slower and weaker compared to that outside lipid 
rafts. In contrast, FAK biosensors targeted to different membrane microdomains revealed that 
FAK activation mainly occurs at lipid rafts in response to both growth factors and integrin 
clustering. Furthermore, I found the differential signaling hierarchy of Src/FAK complex at lipid 
rafts in response to growth factors and integrin clustering, which may contribute to different 
modes of cellular responses to various physiological stimulations.  
In addition to chemical stimulations, this thesis also presents how FAK activity is 
regulated by mechanical environment. FAK activation on fibronectin was more dependent on 
surface rigidity and intracellular tension than on collagen, because integrin activation by 
fibronectin, but not by collagen, is tension-dependent. These results suggest that outside 
mechanical signals can be differently translated inside cells through different interactions 
between specific extracellular molecules and integrin subtypes.    
In summary, this thesis can advance our in-depth understanding on how Src/FAK 
signaling is regulated at microdomains of plasma membrane. The integration of FRET-based 
biosensors and subcellular targeting signals can be unique and powerful tools to study accurate 
signaling events at the subcellular level in live cells. This thesis also provides valuable insights 
on how Src/FAK signaling is regulated upon various chemical and mechanical factors, which 
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will help us to understand growth cone dynamics and cell migration, as well as to develop 
effective therapeutic tools to treat diseases related to neuronal systems and cancer.  
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CHAPTER 1 
GENERAL INTRODUCTION 
 
 
Introduction 
 
Neural circuits are precisely arranged connections between neurons. After initial wiring 
during development, neural circuits are continuously maintained and modified in response to 
environmental factors. The changes in synaptic structures include the formation of new neurites 
and remodeling of dendrites. These occur through growth cone dynamics, e.g. axonal sprouting 
and dendritic remodeling, and the synaptic modifications are essential for the normal function of 
the nervous system. Neural circuits are regulated by various environmental cues including 
mechanical factors as well as chemical factors. Chemical environmental cues include axon 
guidance cues, e.g. ephrin and netrin, and growth factors, e.g. nerve growth factor (NGF) and 
brain-derived neurotrophic factor (BDNF)
1
. Mechanical environmental factors, e.g. extracellular 
matrix rigidity, can also influence the synaptic modifications. It has been shown that neurons 
extend neurites and form branches on soft materials, whereas they are inhibited on hard 
materials
2
. In contrast, astrocytes spread better and become activated on hard materials
3
. Because 
brain tumor changes the nearby mechanical microenvironment, it is important to understand the 
mechanism how the mechanical factors affect the neural circuits. It is also interesting to study 
how the cancerous neurons or glia cells react to their mechanical microenvironment.  
Cell motility and growth cone dynamics are controlled by cytoskeleton and focal 
adhesion dynamics
4
. Focal adhesions (FAs) are the sites where integrins and the associated 
signaling molecules link extracellular matrix to intracellular cytoskeleton structure, and proper 
regulation of focal adhesion dynamics and cytoskeleton reorganization are essential for growth 
cone dynamics and cell migration. Thus, signaling molecules regulating these processes, such as 
Src and focal adhesion kinase (FAK), play crucial roles in growth cone dynamics and cell 
migration. For example, at the tip of growth cone filopodia, Src-dependent tyrosine 
phosphorylation can promote neurites extension
5
. It has been also shown that FAK activity is 
required for the formation of growth cone point contacts, whereas dispensable for the FA 
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assembly in non-neuronal cells
6
. Furthermore, growth cone turning requires local FAK activity
6
. 
Therefore, it is important to understand how Src/FAK signaling is regulated in growth cone 
dynamics and, more generally in cell migration. 
To correctly understand the roles of Src and FAK, it is important to monitor, in live cells, 
how these signaling molecules are spatially and temporally controlled in response to extracellular 
environmental cues. Genetically-encoded biosensors based on fluorescent proteins (FPs) and 
fluorescence resonance energy transfer (FRET) have been developed to visualize molecular 
events in live cells. In fact, a variety of  FRET biosensors allowed the real-time visualization of 
many signaling activities including Src kinase, PI3K, and Rho small GTPases
7-11
 with high 
spatiotemporal resolutions. Furthermore, FRET biosensors can be targeted to different 
subcellular compartments to monitor the local signals
12
. This is important because the 
interactions of signaling molecules are largely dependent on their subcellular environment due to 
different sets and concentrations of intermediate molecules. For example, Src inhibits RhoA at 
the FA sites
13
, but activates RhoA at podosomes
14
; RhoA couples with its effector ROCK at the 
cell rear and a contractile region behind lamellipodium, but co-localizes with another effector 
mDia at the leading edge of a migrating cell
15, 16
. Therefore, subcellular-targeted FRET 
biosensors can be a powerful tool to study the accurate signaling events in live cells.  
In response to environmental cues such as growth factors and extracellular matrix 
molecules, Src and FAK can be activated near plasma membrane through growth factor receptors 
and integrins. Plasma membrane contains different microdomains called lipid rafts, which are 
enriched in cholesterol and sphingomyelin
17
. It has been suggested that lipid rafts play central 
roles in many signaling events, e.g. in growth cone migration and path-finding. For example, 
several guidance receptors were shown to be associated with lipid rafts in neurons
18-20
. Moreover, 
lipid rafts microdomains can segregate ephrin-A and EphA receptors on the same growth cone to 
mediate different signaling pathways
18
. The disruption of lipid rafts can block the chemo-
attractant effect of BDNF, and the subsequent addition of cholesterol to restore lipid rafts can 
rescue the growth cone turning response
21
. However, it is still unclear how Src/FAK activity is 
regulated at these microdomains of plasma membrane. Therefore, it is important to monitor 
Src/FAK activity at the subcellular level to correctly understand their roles in growth cone 
dynamics and cell migration.  
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In this thesis, I developed subcellualr-targeted Src and FAK biosensors based on 
fluorescence resonance energy transfer. In particular, Src/FAK biosensors are targeted into lipid 
rafts or outside lipid rafts of plasma membrane. Utilizing these powerful tools, I studied how 
Src/FAK activity is regulated at the subcellular level, in response to various chemical and 
mechanical environmental factors including growth factors, integrin clustering, surface rigidity, 
extracellular matrix molecules. 
 
 
Overview of the thesis 
 
Including this general introduction in Chapter 1, this thesis is composed of totally 6 
chapters as follows. Chapter 2 includes literature reviews on Src/FAK signaling, Src/FAK 
biosensors based on FRET, and their targeting strategy into subcellular regions, in particular, into 
membrane microdomains lipid rafts. This review was published in the journal of Cellular 
Molecular Bioengineering
12
. 
In Chapter 3, I will present how Src activity is regulated at different compartments of 
plasma membrane. To visualize subcellular Src activity in live cells, a FRET-based Src biosensor 
was modified to tether it in or outside lipid rafts via acylation or prenylation modifications. In 
response to growth factors and pervanadate, Src activation at lipid rafts of plasma membrane was 
slower and weaker, dependent on actin-mediated transportation of Src from perinuclear regions 
to plasma membrane. In contrast, Src activation outside lipid rafts was faster and stronger, 
dependent on microtubules. These results indicate that two distinct Src populations are 
differentially regulated via cytoskeleton at different membrane compartments. These results also 
suggest the close relationship between cytoskeleton and membrane microdomains. This study 
was published in the journal of Chemistry and Biology
22
. 
In Chapter 4, I will show how FAK activity is regulated at different microdomains of 
plasma membrane in response to growth factors and integrin clustering. I will also present how 
FAK/Src activation is regulated at lipid rafts in response to these different physiological 
stimulations. To visualize FAK activity at different membrane microdomains, I developed a new 
FRET-based FAK biosensor and further targeted it into or outside lipid rafts of plasma 
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membrane by lipid modifications. In response to integrin clustering or growth factor stimulations, 
the lipid rafts-targeting FAK biosensor showed a surprisingly stronger response than that at non-
raft regions, suggesting that the FAK activation mainly occurs at lipid rafts microdomains. 
Further experiments revealed that the platelet-derived growth factor (PDGF)-induced FAK 
activation is mediated and maintained by the kinase activity of Src, whereas FAK activation by 
integrin clustering is independent of, and in fact essential for the Src activation. Therefore, these 
results indicate that the molecular signlaing hierarchy between FAK and its close partner Src at 
lipid rafts is differentially regulated upon different physiological stimulations, with FAK acting 
upstream to Src in response to integrin clustering while it is opposite in response to PDGF 
stimulation. This research was published in the journal of Nature Communications
23
. 
In Chapter 5, I will present how FAK activity is regulated by mechanical environment, 
and in particular, how different extracellular matrix (ECM) molecules and specific integrin 
subtypes contribute to the mechanical tension-induced FAK activation. The results in this 
chapter showed that FAK activation on fibronectin (FN) is more dependent on surface rigidity 
than on collagen (CL), because mechanical tension-dependent unfolding of FN molecule is 
required for the activation of integrin 5β124 while CL can directly bind to and activate integrin 
2β1. In fact, FAK can be activated when integrin 5β1 was directly activated by activating 
antibody, even in suspension where no strong tension can be developed. These results suggest 
that outside mechanical signals can be differently translated inside cells through the interactions 
between specific integrin subtypes and ECM molecules. This study is about to submit to the 
journal.   
Finally, in Chapter 6, I will summarize conclusions and overall outcomes of my research 
on the visualization of Src/FAK signaling in response to chemical and mechanical 
microenvironment utilizing the subcellular targeted Src/FAK FRET biosensors. 
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CHAPTER 2 
SRC/FAK SIGNALING AND SUBCELLULAR-TARGETED BIOSENSORS 
BASED ON FLUORESCENCE RESONANCE ENERGY TRANSFER 
 
The Src/FAK complex is involved in signaling pathways in response to various 
environmental cues and plays crucial roles in many cellular processes e.g. cell adhesion and 
migration. It becomes clear that the subcellular localization of Src and FAK is crucial for their 
activities and functions. In this chapter, I will first overview the structure and activation 
mechanisms of Src and FAK. Next their signaling pathways, in particular in cell migration, will 
be discussed. I will then introduce genetically-encoded biosensors based on fluorescence 
resonance energy transfer (FRET) to visualize Src/FAK activities in live cells with high 
spatiotemporal resolutions. Finally, various targeting peptides motifs to target FRET biosensors 
to different subcellular regions will be discussed. The integration of FRET-based biosensors and 
these targeting motifs allows the monitoring of local molecular interactions at the subcellular 
level. In particular, I will introduce the targeting motifs to different microdomains of plasma 
membrane. In summary, genetically-encoded FRET biosensors integrated with subcellular 
compartment-targeting signals can provide powerful tools for the visualization of subcellular Src 
and FAK activities in live cells and advance our in-depth understanding of Src/FAK functions at 
different subcellular compartments.  
 
 
The structure of Src and FAK and their cellular signaling 
 
The structure and activation mechanism of Src and FAK 
Non-receptor tyrosine kinases Src and FAK play important roles in cell differentiation, 
adhesion, migration and invasion
1-4
. The gene encoding the mutated and active form of Src, v-
Src, was isolated as the first oncogene from the Rous sarcoma virus
5
. The cellular homologue, c-
Src, was identified in 1978 as the first proto-oncogene and its product protein as the first tyrosine 
kinase
6-8
. Focal adhesion kinase (FAK) was later discovered as one of the Src substrates at focal 
adhesions, the contact sites of a cell on extracellular matrix (ECM)
9
.  
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Src contains a SH4, a SH3, a SH2, a tyrosine kinase domain, and a regulatory C-terminal 
tail
2
. At its rest state, Src exists as a closed conformation mainly through the intramolecular 
binding between the phosphorylated C-terminal Tyr527 and SH2 domain. This closed 
conformation is also facilitated by the interaction between SH3 domain and the linker region
10
. 
When the closed conformation is disrupted, the kinase domain of Src can be exposed to 
phosphorylate its substrates. Therefore, Src activation mechanism includes the de-
phosphorylation of Tyr527 by phosphatases, and the competitive bindings of phosphorylated 
tyrosines or proline-rich domains from other molecules with the Src SH2 or SH3 domain, 
respectively
10
. For example, the auto-phosphorylated Tyr397 of FAK can recruit and bind to 
SH2 domain of Src, causing the activation of Src.  
Similar scenario exists for the FAK activation mechanism. FAK contains an N-terminal 
FERM (protein 4.1, ezrin, radixin and moesin homology) domain, a kinase domain, and a C-
terminal focal adhesion targeting (FAT) domain
11
. When FAK was inactive, the N-terminal 
FERM domain directly binds to and masks the kinase domain. At the same time, the FERM 
domain also sequesters the linker region containing the major auto-phosphorylation site Tyr397
12
. 
When this auto-inhibited conformation of FAK is destabilized, Tyr397 can be phosphorylated, 
creating binding site for the SH2 domain of Src. Src can be subsequently recruited to 
phosphorylate Tyr516 and Tyr517 in the kinase domain of FAK, causing the further activation of 
FAK. Thus, Src and FAK work closely to form a molecular complex, which regulates numerous 
signaling pathways, in particular, in cell adhesion and migration
11
.  
 
Src/FAK signaling in cell migration 
Cell migration is a cyclic process consisting of cell polarization, protrusion and adhesion 
formation at the leading edge, and retraction at the rear
13
. This highly integrated process requires 
the coordinated regulation of focal adhesion (FA) dynamics and cytoskeleton reorganization, 
which are largely controlled by Src/FAK signaling pathways. First, Src/FAK complex is 
involved in FA dynamics. For example, Src and FAK can be rapidly phosphorylated upon cell 
adhesion to participate in the FA formation
2, 9, 14
. Other studies showed that fibroblasts deficient 
in FAK
15
 or expressing kinase-defective Src
16
 displayed increased sizes in FAs and decreased 
speeds in migration, suggesting Src/FAK complex is involved in both FA assembly and 
disassembly. Second, Src/FAK complex has also been shown to regulate the reorganization of 
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cytoskeleton
2, 11
. For example, FAK-mediated stabilization of local microtubules can result in 
cell polarization
17
, which is the crucial step for the directional migration
13
. In addition, the 
Src/FAK complex can regulate actin reorganizations through Rho GTPases to regulate cell 
protrusion and migration
18
. Therefore, the Src/FAK complex plays crucial roles in cell 
adhesion/migration by regulation of FA dynamics and cytoskeleton reorganization.  
 
Focal adhesion dynamics 
Focal adhesion is composed of structural and regulatory protein complexes coupling the 
membrane receptor integrins and the extracellular matrix (ECM), providing an anchor on which 
the cell can push or pull over ECM
19
. It becomes clear that the integrin signaling involves 
complex and robust molecular networks
11, 20
. The Src/FAK complex is part of the networks and 
can serve as a positive regulator for the FA assembly by recruiting related signaling molecules. 
FAK can localize at FAs via the focal adhesion targeting (FAT) domain at its C-terminus, which 
can bind integrin-associated adaptor proteins, paxillin and talin
19
. Integrin clustering upon cell 
adhesion causes FAK autophosphorylation at Tyr397, creating the binding site for the SH2-
domain of Src
21
. The Src/FAK complex can cause the activation of type I phosphatidylinositol 
phosphate kinase  (PIPKI) to increase the production of phosphatidylinolsitol-(4, 5)-
biphosphate (PIP2)
22
. PIP2 can function as binding sites for other focal adhesion molecules such 
as -actinin, vinculin, and talin23, to promote the FA assembly. Thus, the Src/FAK complex can 
facilitate the formation of FA by modulating lipid composition of the plasma membrane and 
creating docking sites to recruit FA proteins. 
The disassembly of FAs at the rear and the retraction of the trailing edge of the cell can 
facilitate the complete of the migration cycle and enable the cell translocation. The FAs near the 
leading edge are also disassembled as new FAs assembled nearby in the migration direction. It 
becomes clear that the Src/FAK complex plays important roles in FA turnovers via various 
routes. First, the Src/FAK complex can recruit Grb2 into FAs and the subsequent ERK activation 
can displace FAK from paxillin, causing the disassembly of focal adhesion complexes. The 
autophosphorylation of FAK at Tyr397 can recruit Src, which in turn phosphorylates Tyr925 in 
the FAT domain of FAK. The phosphorylated Tyr925 creates the binding site for the SH2 
domain of Grb2. Because the binding site of Grb2 in the FAK FAT domain at phosphorylated 
10 
 
Tyr925 partially overlaps with that of paxillin, FAK with phosphorylated tyrosine at 925 can be 
masked by Grb2, and decoupled from paxillin and focal adhesions
24
. The recruited Grb2 can also 
lead to the activation of Ras and Erk2, which causes the phosphorylation at serine 910 in the 
FAT domain of FAK. This serine 910 phosphorylation can further facilitate the dissociation of 
FAK from paxillin and cause the focal adhesion disassembly
25
.  
Second, the Src/FAK complex can influence the focal adhesion disassembly through 
proteolysis. Calpain is a protease which cleaves talin and FAK. Calpain can be up-regulated by 
the Src/FAK-mediated Erk2 activity
26
 as well as local Ca
2+
 influx
27
 to cause the disassembly of 
focal adhesions. Matrix metalloproteases (MMPs), which can be regulated by Ras/ERK2 
signaling, can also cleave the binding between focal adhesions and ECM to facilitate the FA 
disassembly
28
. Therefore, the Src/FAK complex can mediate the focal adhesion turnover via the 
ERK activation
11
.  
Besides the ERK signaling pathway, the Src/FAK complex can facilitate FA turnover by 
affecting the linkage between FA and actin cytoskeleton. -Actinin is an actin-associated protein 
which can bind to vinculin and zyxin, thus crosslinking actin stress fiber to the focal adhesion. 
The Src/FAK complex can phosphorylate -actinin at tyrosine 12, which subsequently reduces 
the binding affinity of -actinin toward actin29. This reduced linkage between focal adhesions 
and actin cytoskeleton can facilitate the focal adhesion turnover. As such, the Src/FAK complex 
can promote the disassembly of focal adhesion coordinating multiple molecular signaling 
pathways.  
 
Cytoskeleton reorganization 
It has been shown that the integrins-induced FAK activation affects the stabilization of 
dynamic microtubules via RhoA and its effector mDia
17
. In fact, FAK is required for the 
localized stabilization of microtubule. This local microtubule stabilization in the leading edge of 
a migrating cell can facilitate cell polarization by mediating asymmetric distribution of adhesion 
molecules and membrane components, allowing the directional cell migration. Thus, FAK 
facilitates cell polarization through microtubule stabilization during cell migration.  
The reorganization of actin filaments is also crucial for cell protrusion, which consists of 
two different types of actin organizations: lamellipodia and filopodia. Lamellipodia is composed 
11 
 
of branched actin filaments whereas filopodia is a structure of fine, parallel actin bundles
30
. The 
Src/FAK complex can regulate actin remodeling during cell migration through Rho small 
GTPases. For example, the Src/FAK complex is involved in the formation of lamellipodia 
through Rac1 signaling
11
. The adapter protein p130CAS can bind to the proline-rich domain of 
FAK via its SH3 domain and be phosphorylated by Src kinase. The phosphorylated p130CAS 
can create binding sites for the SH2 domain of Crk. Crk can then recruit DOCK180, a Rac 
guanine exchange factor (GEF), which subsequently activates Rac1. The phosphorylated Tyr397 
of FAK can also recruit the SH2 domain of PI3K. The local accumulation of PIP3 caused by the 
PI3K activation can recruit another Rac GEF Vav2 , which provides a second pathway for Rac1 
activation
11
. Activated Rac1 can then promote the formation of lamellipodia through the 
activation of WAVE and Arp2/3 proteins, as well as the increased actin polymerization and 
branching. Thus, the Src/FAK-mediated Rac1 activation can induce the lamellipodia protrusion 
in the leading edge, which is crucial for the cell migration.  
Filopodia, a fine actin bundle structure in the leading edge, can sense and explore the 
extracellular environment of a migrating cell to guide cell migration. FAK can influence Cdc42 
and its effecter N-WASP to promote the formation of filopodia
31
. In fact, FAK can 
phosphorylate N-WASP at tyrosine 256, which can influence the subcellular localization of N-
WASP to regulate filopodia. Therefore, the Src/FAK complex can regulate actin reorganization 
during cell migration through Rho GTPases. 
 
 
Live-cell imaging of Src/FAK signaling by FRET 
 
Live-cell imaging can provide tremendously more insights than traditional biochemical 
assays
32, 33
, which usually require the cells to be killed
34
. The discovery of green fluorescence 
protein (GFP) and recent advances in fluorescence proteins (FPs) enabled visualizing of the 
distribution of a protein as well as tracking of its locations in live cells
35, 36
. Genetically-encoded 
biosensors based on FPs and fluorescence resonance energy transfer (FRET) can further allow 
the visualization and quantification of the molecular activity at subcellular levels with high 
spatiotemporal resolution. Fluorescence proteins for the FRET pair of biosensors can be chosen 
12 
 
when the emission wavelength of a donor FP overlaps with the excitation wavelength of an 
acceptor FP. If these FRET pair FPs are in proximal with appropriate orientation, fluorescence 
resonance energy can be transferred to the acceptor when the donor is excited.  
Substrate-based kinase FRET biosensors can be developed accordingly by connecting a 
specific substrate peptide and its binding domain between a donor and an acceptor FP (Fig. 2-1). 
When the target kinase is active in cells, it can phosphorylate the specific substrate in the 
biosensor, and the phosphorylated substrate can then bind to the intramolecular binding domain, 
e.g. SH2 domain. This intramolecular interaction can cause the conformation change of the 
biosensor, which results in the FRET change (Fig. 2-1). Thus, the molecular activity of the target 
kinase can be visualized in live cells by monitoring the FRET change. In this section, I will 
discuss the development of FRET biosensors for the visualization of Src and FAK activities in 
live cells. 
 
Src biosensors based on FRET 
A FRET-based Src biosensor was initially developed using the strategy of substrate-
based kinase biosensors described above
37
. When the active Src phosphorylates the tyrosine of 
the substrate, the phosphotyrosine binds to the SH2 domain in the biosensor, causing the FRET 
change between a FRET pair FPs, enhanced cyan fluorescence protein (ECFP) and enhanced 
yellow fluorescence protein (EYFP). This Src biosensor showed around 30% of FRET changes 
in vitro when subjected to kinase assay in the presence of Src. However, the substrate of the 
biosensor, selected from in vitro library screening, also responded to EGFR, Abl and Lck
37
.  
Because the specific FRET response is one of the essential features for the successful 
biosensor, the second version of Src biosensor was subsequently developed to improve the 
specificity
38
. This Src biosensor has the substrate peptide derived from a Src substrate p130CAS, 
which can be specifically phosphorylated by Src. In addition, the intermolecular FRET, which 
can be caused by the dimerization tendency of FPs, was eliminated by the mutation of Ala206 to 
Lys in FPs. This improved biosensor displayed a high sensitivity and specificity toward Src 
kinase, and allowed the successful visualization of a wave propagation of Src activation in 
human umbilical vein endothelial cells (HUVECs) upon a mechanical stimulation induced by a 
laser-tweezer-traction of a bead seeded on top of the cell
38
.  
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Recently, ECFP and YPet were shown to serve as an improved FRET pair to allow a 
significantly enhanced dynamic range for various FRET biosensors, including the Src FRET 
biosensor
39
. This third version of Src biosensor with significantly enhanced sensitivity can allow 
the detection of subtle, but physiologically crucial signals
39
. For example, this improved Src 
biosensor has allowed the visualization of a transient Src activation in bovine aortic endothelial 
cells (BAECs) upon vascular endothelial growth factor (VEGF) stimulation
39
. With this 
biosensor, a rapid activation of Src upon mechanical stretch was also observed to have a speed 
40 times faster than chemical stimulation
40
.  
 
FAK biosensors based on FRET 
Several FAK biosensors based on FRET have been developed. One of the FAK 
biosensors consists of a donor FP and an acceptor FP separately fused to FAK and a double-SH2 
domain, respectively
41
. This system is designed to report the intermolecular FRET increase upon 
the interaction between the autophosphorylated Tyr397 and SH2 domains. However, this 
intermolecular FRET system has some limitations compared to intramolecular FRET system. 
First, it is difficult to determine whether the FRET signals are engendered from the binding of 
the double-SH2 domain to the phosphorylated Tyr397 or other tyrosine sites in FAK. In addition, 
the acceptor/donor ratio at various subcellular locations is not uniform due to the different 
expression and localization of donors and acceptors. Thus, this approach requires more 
sophisticated mathematical tools to quantify the signals than a simple donor/acceptor ratio in live 
cells.  
Another two FAK biosensors were independently developed to detect the intramolecular 
FRET upon the conformational change of FAK
41, 42
. It has been shown that, in the auto-inhibited 
state of FAK, the N-terminal FERM domain binds to the kinase domain to block the 
phosphorylation of the active loop of FAK
12
. This closed conformation can be open when FAK 
is activated. Accordingly, ECFP was fused at the N-terminus of FAK and EYFP inserted at the 
linker region between the FERM and the kinase domain of FAK to develop these two FAK 
biosensors. Therefore, the conformational change of FAK, representing FAK activation, can 
cause the FRET change of these biosensors. Despite their similar design strategies, the FRET 
responses of these two biosensors upon FAK activation were opposite to each other: increasing 
in one case
42
 while decreasing in the other
41
, suggesting a complex FRET mechanism of these 
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reporters. The inserted FP at the linker regions may also partially expose the kinase domain, 
causing an elevated enzymatic activity of the biosensors comparing to the endogenous FAK
41
. 
Also, the expression of the full-length FAK-containing biosensors may lead to the perturbation 
of the endogenous downstream signaling pathways, possibly by introducing extra enzymatic 
activities of FAK in host cells.  
In my recent study, a substrate-based FAK FRET biosensor has been developed
43
. This 
FAK biosensor is composed of a specific substrate and Src SH2 domain between an enhanced 
FRET pair ECFP and YPet. The substrate sequence is derived from the linker region 
encompassing Tyr397 of FAK. When Tyr397 in the substrate of the biosensor is phosphorylated 
by the active FAK (trans-activation), the phosphorylated substrate can then bind to the 
intramolecular SH2 domain, causing a conformation change and a decrease in FRET. This FAK 
biosensor has a design strategy similar to that of the Src FRET biosensor, with the only 
difference on the substrate peptide. In vitro kinase assay showed no FRET change of this FAK 
biosensor by addition of the active Src, indicating the specificity of the biosensor toward FAK, 
but not Src. In addition, the over-expression of this FAK biosensor did not affect the 
phosphorylation of ERK, suggesting the biosensor did not affect endogenous downstream 
signaling pathways
43
. 
 
 
Subcellular visualization of Src/FAK signaling 
 
Src/FAK complex is involved in numerous crucial signaling pathways. The tight 
spatiotemporal regulation of the Src/FAK activity is crucial to precisely control these various 
signaling events. In particular, proper subcellular localization is important because molecular 
interactions are largely dependent on the subcellular environment due to different sets and 
concentrations of molecular intermediates at different subcellular regions. Indeed, Src can be 
attracted near the plasma membrane via its N-terminal myristoylation signal and polybasic amino 
acids to become functional
2
. FAK also contains the focal adhesion targeting (FAT) domain in its 
C-terminus, which can interact with integrin-binding proteins, e.g. paxillin and talin, to lead FAK 
toward the membrane regions
11
. As such, Src and FAK can be activated at the plasma membrane 
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in response to various stimulations, e.g. integrin clustering and growth factors. However, it has 
been suggested that the plasma membrane is not uniform in structure and components and 
contains different microdomains compartments, e.g. lipid rafts. Lipid rafts are rich in cholesterol, 
sphingomyelin, and saturated fatty acids, and known to function as segregated signaling 
platforms. Therefore, the subcellular targeting of the Src or FAK biosensor is essential to 
visualize and study the activities of Src and FAK with high precision in space and time. In this 
section, I will discuss several targeting motifs to different subcellular regions, and examples of 
their applications in the subcellular targeting of FRET-based biosensors. 
 
Protein targeting signals 
Cells contain separate compartments including nucleus, mitochondria, endoplasmic 
reticulum (ER), and plasma membrane. Unlike diffusive dyes, e.g. Fura-2, one of the advantages 
of genetically encoded FRET biosensors is that they can be engineered to localize at the specific 
subcellular position and report the local activity of the target molecules. Many protein targeting 
signals have been discovered, e.g. nuclear localization signal (NLS)
44
, nuclear export signal 
(NES)
45
, the endoplasmic reticulum (ER)
46
 and plasma membrane targeting signals
47, 48
 (Table 2-
1). These short peptide sequences are identified originally from endogenous proteins that are 
localized at the specific subcellular compartments.  
The fusion of these specific tags to the engineered proteins, such as FRET-based 
biosensors, can enable the targeting of the proteins to the desired subcellular locations in a live 
cell. For example, a FRET-based Ca
2+
 biosensor was targeted to ER, a major calcium store, to 
confirm the Ca
2+
 oscillation in human mesenchymal stem cells
46
. The subcellular activity of JNK 
was also studied by a FRET-based JNK biosensor targeted to nucleus, mitochondria, and plasma 
membrane
44
. The FRET biosensor detecting the activity of membrane type 1 matrix 
metalloproteinase (MT1-MMP) was tethered outside of the plasma membrane using the targeting 
sequences adopted from the transmembrane domain of platelet-derived growth factor (PDGF) 
receptor β49. Thus, this biosensor can successfully visualize the MT1-MMP activity dissolving 
the extracellular matrix in response to epidermal growth factor (EGF). Therefore, FRET-based 
biosensors with specific targeting signals can be powerful tools to study the more accurate 
molecular signaling events in live cells with high spatiotemporal precisions. 
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The targeting signals to the microdomains of the plasma membrane 
It has been shown that lipid modifications, e.g. acylation and prenylation, are sufficient to 
target a protein into different microdomains of plasma membrane
50
. The FRET biosensor with 
these specific targeting signals can allow the live-cell imaging of molecular activity in or outside 
of lipid rafts, whose size is beyond the resolution of the microscope. For example, my recent 
study showed that the local Src activity at lipid rafts of the plasma membrane is different from 
those at the general membrane regions
48
. The targeting signal for lipid rafts (Lyn-tag) contains 
the acylation substrate derived from Lyn kinase (Fig. 2-2). The N-terminal glycine and cysteine 
sites at this acylation sequence can be myristoylated and palmitoylated so that the tagged protein 
modified with these long saturated fatty acids can be incorporated into the lipid raft 
microdomains of the plasma membrane. Non-raft targeting signal (KRas-tag) was adopted from 
KRas which has C-terminal polybasic amino acids and a cysteine site for prenylation 
modification (Fig. 2-2). The tagged protein with this long unsaturated fatty acids and positively 
charged amino acids can be attracted to the general membrane regions of the plasma membrane, 
but not partitioned into lipid rafts. As such, the Lyn- or KRas-tag can be added in the N- or C-
terminus of the FRET-based biosensor, respectively, to lead and localize the biosensor at 
different microdomains of the plasma membrane.  
These differentially localized Lyn- and KRas-tagged biosensors at the plasma membrane 
can be confirmed by modeling their movement in the cell geometry by two-dimensional 
diffusion simulation based on the finite element methods
51, 52
. Utilizing the images obtained by 
the fluorescent recovery after photobleach (FRAP) experiments, the finite element simulation 
and analysis have revealed that the Lyn-tagged biosensors are tightly attached to the membrane, 
with a slower motion than that of the KRas-tagged biosensors. The KRas-tagged biosensors 
appeared to be associated to the membrane with less stable binding state. The cytosolic 
biosensors, on the other hand, moved in 3D compartments between the nucleus and cytoplasm, 
which cannot be accurately described by a 2D diffusion model
51
. These results confirmed that 
the Lyn- and KRas-tags can position the biosensors at different subcellular locations at the 
plasma membrane.  
 
 
17 
 
Summary 
 
In this chapter, I discussed the signaling pathways of Src/FAK complex involved in cell 
migration. I also introduced the progress in the development of FRET-based Src/FAK biosensors, 
and their targeting strategy to efficiently detect the Src/FAK activity at the subcellular regions. 
The integration of subcellular targeting motifs with FRET biosensors provides useful tools to 
visualize the local activity of proteins of interests in live cells. This will allow our in-depth 
understanding of the complex molecular signaling events in live cells.  
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Figure 2-1. General design of a tyrosine kinase biosensor based on FRET.  
A typical kinase biosensor based on FRET is composed of a specific substrate peptide and its 
binding domain between a donor and an acceptor FPs. When the specific substrate in the 
biosensor is phosphorylated by active kinase, it can bind to the nearby binding domain, e.g. 
SH2 domain. This intramolecular interaction can cause the conformation change of the 
biosensor, which results in the FRET change.  
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Figure 2-2. Targeting of FRET biosensor into microdomains of plasma membrane.  
The targeting signal into lipid rafts (Lyn-tag) contains the acylation substrate derived from Lyn 
kinase. N-terminal glycine and cysteine can be myristoylated and palmitoylated. The tagged 
protein modified with these long saturated fatty acids can be incorporated into the lipid-raft 
microdomains of the plasma membrane. Non-raft targeting signal (KRas-tag) was adopted from 
KRas which has polybasic amino acids and a C-terminal cysteine site for prenylation 
modification. The tagged protein with this long unsaturated fatty acids and positively charged 
amino acids can be attracted to the general membrane regions of the plasma membrane, but 
not into lipid rafts. 
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Table 2-1. The sequences of various subcellular targeting signals.  
 
 
Target site Amino acids sequences  Location  References  
Nucleus 
localization signal 
PKKKRKVEDA  C-terminal  (28)  
Nucleus export 
signal  
LPPLERLTL  C-terminal   
Endoplasmic 
Reticulum  
MLLPVLLLGLLGAAAD 
KDEL  
N-terminal  
C-terminal  
(27)  
Mitochondria MAIQLRSLFPLALPGMLALLGW
WWFFSRKK  
N-terminal  (28)  
Outer plasma 
membrane  
AVGQDTQEVIVVPHSLPFKVVVI
SAILALVVLTIISLIILIMLWEKKPR  
C-terminal  (29)  
Lipid rafts at 
plasma membrane  
MGCIKSKRKDNLNDDE  N-terminal  (31, 32)  
Non-lipid rafts at 
plasma membrane  
KKKKKKSKTKCVIM  C-terminal  (31, 32)  
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CHAPTER 3 
DIFFERENTIAL SRC ACTIVATIONS AT MEMBRANE 
MICRODOMAINS 
 
In this chapter, I studied how spatiotemporal Src activity is regulated at different 
membrane compartments, which function as segregated signaling platforms. To visualize local 
Src activity in live cells, a FRET-based Src biosensor was targeted in or outside of lipid rafts at 
plasma membrane, via acylation or prenylation modifications on targeting tags either directly 
fused to the biosensor or coupled to the biosensor through an inducible heterodimerization 
system. In response to growth factors and pervanadate, the Src activity at lipid rafts was slower 
and weaker. This Src activity at lipid rafts was dependent on the actin-mediated transportation of 
Src kinases from perinuclear regions to the plasma membrane. In contrast, the Src activity in 
non-rafts was faster and stronger, dependent on microtubules. Therefore, Src activity is 
differentially regulated via cytoskeleton at different membrane compartments. 
 
 
Introduction 
 
The non-receptor tyrosine kinase Src plays critical roles in numerous cellular processes
1
. 
For example, Src kinase regulates cell migration by the phosphorylation of the adapter protein 
p130CAS to recruit Crk and DOCK180/ELMO, which can activate Rac1 to induce the formation 
of lamellipodia at the leading edge of migrating cells
2-4
. In addition, Src binds to the 
autophosphorylated tyrosine 397 of focal adhesion kinase (FAK) via its SH2 domain and 
phosphorylates tyrosine 925 of FAK. Grb2 can then bind to this site and displaces FAK from 
paxillin, causing focal adhesion turnover in the trailing edge of the cell
5
. Src is also involved in 
the proliferation through the Ras-MAPK pathway and in cell survival through the PI3K-Akt 
signaling
6
. To mediate such a variety of cellular signaling transduction, the activation and 
function of Src kinase require a highly coordinated regulation in space and time. Indeed, Src at 
resting state was shown to localize mainly in the endosomes near perinuclear region and 
microtubule organizing center (MOTC)
7
. Upon stimulation, active Src can be translocated to the 
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plasma membrane via the actin cytoskeleton
8
. There is also evidence that Src regulates down-
stream signals differently depending on its subcellular localization. For example, Src induces the 
p190RhoGAP activation and subsequently inhibits RhoA at the focal adhesion sites
6
, but 
activates RhoA at podosomes
9
. Therefore, the visualization of the dynamic activation pattern of 
Src at subcellular environments will provide critical insights on our understanding of the 
molecular mechanism regulating cellular functions.   
The plasma membrane is not uniform in structure
10
 and has different nano-size 
compartments, e.g. lipid rafts, which are rich in cholesterol, sphingomyelin, and saturated fatty 
acids
11
. These compartmental structures are involved in the localization and regulation of 
intracellular signaling molecules
12, 13
. For example, Src family kinases (SFKs) have been shown 
to be transported to distinct compartments of plasma membrane through different types of 
endosomes
14
. SFK members such as Lyn and Fyn can reside in lipid rafts of the plasma 
membrane
10
, via their N-terminal sequences after myristoylation and palmitoylation
15
. However, 
Src kinase has only myristoylation motif and it remains controversial whether Src kinase 
localizes within lipid rafts at the plasma membrane
16-21
. The detergent extraction method has 
been widely used to study the lipid rafts based on its detergent-resistant property. In mouse 
fibroblasts, Src was shown to be excluded from the detergent-resistant membrane (DRM) 
fractions in one study while another publication suggested that Src resides in DRM fraction
16, 21
. 
Different groups also reported different Src localizations in PC12 cells
19, 20
. This inconsistency is 
likely attributed to the controversial effects of non-ionic detergents used in these reports for 
isolating DRMs, which, however, may not exactly correspond to lipid rafts in living cells and 
may be isolated from membranes that do not contain rafts before detergent extraction
22, 23
. Thus, 
the development of advanced methods is required to study the lipid rafts in live cells.   
Previous studies have shown that genetically-encoded biosensors, based on fluorescence 
resonance energy transfer (FRET), are capable of monitoring various cellular events in live cells 
with high spatial and temporal resolution
24
. Src FRET biosensor which can detect Src activity in 
the cytoplasm was previously developed
25
. In this chapter, this Src FRET biosensor was further 
coupled to membrane-targeting motifs, either by direct fusion or by an inducible 
heterodimerization system. As such, the biosensor can be directed to tether at different 
compartments of plasma membrane, where the local Src activity in live cells can be monitored 
and quantified in real time. The results revealed that the Src activity is differentially regulated at 
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different compartments of the plasma membrane, mediated by different sets of cytoskeletal 
components.  
 
 
Materials and Methods 
 
Cell culture and reagents 
HeLa, mouse embryonic fibroblast (MEF) cells were purchased from ATCC. The 
Src/Fyn/Yes triple knockout MEF (SYF -/-) was a generous gift from Dr. Jonathan Cooper, Fred 
Hutchinson Cancer Research Center. Cell culture reagents were obtained from Invitrogen. Cells 
were maintained in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal 
bovine serum (FBS), 2 mM L-glutamine, 1 unit/ml penicillin, 100 g/ml streptomycin, and 1 
mM sodium pyruvate. Cells were cultured in a humidified 95% air, 5% CO2 incubator at 37C.  
Actin filaments or microtubules were disrupted by incubation for 1 hr with cytochalasin 
D (Sigma; 1 M) or nocodazole (Sigma; 1 M), respectively25. Epidermal growth factor (EGF) 
and platelet-derived growth factor (PDGF) were purchased from Sigma.  
 
DNA constructions and plasmids 
The Lyn-Src biosensor was previously described
25
. The KRas-Src biosensor was 
constructed by fusing 14 amino acids of KRas-prenylation sequences (KKKKKKSKTKCVIM) 
to the C-termini of Src biosensor using polymerase chain reaction (PCR). For the FRB-Src 
biosensor, PCR was applied to create HindIII and BamHI sites flanking FRB. The PCR product 
was fused to the N-termini of Src biosensor in pcDNA3 (Invitrogen). Lyn-FKBP or KRas-FKBP 
was constructed by PCR of FKBP with Lyn-acylation sequence
25
 incorporated into the sense 
primer or KRas-prenylation sequence into the anti-sense primer, respectively. The PCR products 
of Lyn- or KRas-FKBP were inserted into pcDNA3 using EcoRI/HindIII restriction enzyme sites.  
mCherry--actin was a kind gift from Dr. Roger Y. Tsien, University of California, San Diego. 
The expression of mCherry-actin, Scar1WA, and EGFP-wt Src was previously described
8, 26
. 
 
Preparation of pervanadate  
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Pervanadate solution was prepared as previously described
27. In brief, 10 μl of 100 mM 
Na3VO4 and 50 μl of 0.3% H2O2 in 20 mM HEPES (pH 7.3) were mixed in 940 μl of H2O. After 
5 min, catalase (CalBiochem, 260 units/ml) was added to release excess H2O2, which resulted in 
1 mM pervanadate. 
 
Inducible heterodimerization system 
The ARGENT
TM
 regulated heterodimerization kit was obtained from ARIAD 
Pharmaceuticals, Inc. The dimerization domain FKBP was conjugated to Lyn-acylation
25
 or 
KRas-prenylation sequences for membrane targeting. The other dimerization domain FRB was 
conjugated to the cytosolic Src biosensor. The cells were co-transfected with the FRB-
conjugated Src biosensor and a membrane-targeted FKBP domain (either KRas-FKBP or Lyn-
FKBP). Upon the addition of rapamycin analogue AP29167 (1 M), the FRB-conjugated Src 
biosensor can be induced to associate with the membrane-bound FKBP and be targeted to 
different compartments at plasma membrane. 
 
Immunoprecipitation and immunoblotting  
HeLa cells expressing the KRas- or Lyn-Src biosensors were starved with 0.5% FBS for 
36-48 hr before PVD (20 μM) stimulation or kept as a control. Cell lysates from the various 
samples were subjected to immunoprecipitation (IP) with an anti-GFP antibody (Abcam) to pull 
down the expressed biosensors, followed by immunoblotting (IB) with an anti-phospho-tyrosine 
antibody (Santa Cruz Biotechnology) to display the tyrosine phosphorylation level, or with an 
anti-GFP antibody to show the expressed protein levels. The molecular weight of the Src 
biosensors is about 70 kDa. 
 
Image acquisition 
During imaging, the cells were cultured on cover-glass-bottom dishes and maintained in 
0.5% FBS CO2-independent medium (Gibco BRL) at 37°C. Images were collected by a Zeiss 
Axiovert inverted microscope and a cooled charge-coupled device (CCD) camera (Photometrics, 
Tucson, AZ) using MetaFluor 6.2 software (Universal Imaging) with a 420DF20 excitation filter, 
a 450DRLP dichroic mirror, and two emission filters controlled by a filter changer (475DF40 for 
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CFP and 535DF25 for YFP). The mCherry-actin images were collected using a 560DF40 
excitation filter, a 595DRLP dichroic mirror, and a 653DF95 emission filter. A neutral density 
filter was used to control the intensity of the excitation light. The fluorescence intensity of non-
transfected cells were quantified as the background signals and subtracted from the CFP and 
YFP signals on transfected cells. The pixel-by-pixel ratio images of CFP/YFP were calculated 
based on the background-subtracted fluorescence intensity images of CFP and YFP by the 
MetaFluor program to allow the quantification and statistical analysis of FRET responses by 
Excel (Microsoft) and Matlab (The MathWorks). The emission ratio images were shown in the 
intensity modified display (IMD) mode
25
.   
 
Statistical analysis of FRET response of Src biosensors 
The response of Src FRET ratio, r(t), under PVD stimulation can be analyzed based on 
the Gaussian function model. First, the velocity of FRET change, or the discrete derivative of r(t), 
can be approximated by the central difference of the FRET ratio,   
 
( ) ( ( ) ( )) / (2 )v t r t t r t t t      
 
where v(t) stands for the discrete velocity at time t; and t  is the time interval between two 
consecutive FRET ratio values. Using a nonlinear least-square method with the trust-region 
algorithm in the MATLAB curve fitting toolbox, the velocity curve is then plotted and fitted to 
the Gaussian equation, 
2
2
1 ( )
( ) exp( )
22
t
v t A



     
 
to determine the parameters A,   and   and their 95% confidence intervals 28, 29. The 
parameter A denotes the area under the Gaussian curve and hence represents the total FRET 
change upon stimulation. The parameter   measures the half width of the curve at the 60% of 
the maximum vi, thus characterizes the reaction rate. The parameter   denotes the time value at 
the maximal vi in the Gaussian curve, hence represents the time point where the reaction reaches 
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the maximal rate. The parameter T0 was calculated as the time value when 5% of the total FRET 
ratio change was achieved in the Gaussian curve (T0 = -1.64485 ).  
 
 
Results 
  
A faster and stronger Src activation at non-raft membrane compartments 
To monitor the local Src activity in different compartments at the plasma membrane, the 
Src FRET biosensor
25
 was genetically modified to be tethered in or outside of lipid rafts (Fig. 3-1 
and 3-2). It has been shown that lipid modification, e.g. acylation and prenylation, is sufficient to 
target a protein into the different microdomains of plasma membrane
15
. The lipid raft-targeting 
biosensor (Lyn-Src biosensor) was hence constructed by genetically fusing acylation substrate 
sequences derived from Lyn kinase to the N-terminus of the cytosolic Src biosensor
25
. N-
terminal glycine and cysteine in the acylation sequences can undergo myristoylation and 
palmitoylation
30
, which partition the biosensor into lipid rafts
10
. The non-raft biosensor (KRas-
Src biosensor) was developed by introducing prenylation sequences (KKKKKKSKTKCVIM) 
from KRas to the C-terminus of the cytosolic Src biosensor. Prenylation on the C-terminal 
cysteine residue and the neighboring polybasic amino acids can target the biosensor to the non-
raft regions
15
. In fact, different mobilization properties of Src biosensors in the microdomains of 
the plasma membrane have been revealed in the recent publication using fluorescence recovery 
after photobleaching (FRAP) analysis
31
. I have further conducted the in vitro kinase assay on the 
cytosolic, Lyn- and KRas-tagged biosensors. Fluorescence emission spectra of the purified 
biosensors were measured with CFP excitation wavelength (430 nm), and the emission ratios of 
donor/acceptor (478 nm/526 nm) of each biosensor were calculated before and after the addition 
of active Src kinase. The results revealed that the responses of these three biosensors are very 
similar in kinetics and magnitude upon Src phosphorylation (Data not shown). Therefore, FRET 
changes of the Lyn- and KRas-Src biosensors can be used to monitor the apparent Src activity at 
different compartments of the plasma membrane. 
To investigate the spatiotemporal Src activation, I first examined the FRET response of 
different Src biosensors in response to growth factor stimulations (Fig. 3-3). The results revealed 
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that both epidermal growth factor (EGF, 50 ng/ml) in HeLa cells and platelet-derived growth 
factor (PDGF, 50 ng/ml) in mouse embryonic fibroblasts (MEFs) induced significant FRET 
changes of the Src biosensors, with a faster and stronger response from the non-raft KRas-Src 
biosensor when compared to that of the Lyn-Src biosensor at rafts (Fig. 3-3). In fact, the non-raft 
KRas-Src biosensor responded promptly to reach the peak (50-60% change) within 3-5 min, 
whereas the response of raft Lyn-Src biosensor was much slower and weaker (10-20% change). 
These results suggest a faster and stronger Src activity enhancement in non-raft regions at the 
plasma membrane upon growth factor stimulations. 
Recent evidence suggests that growth factors may regulate signaling transduction via the 
activation of receptors as well as generation of reactive oxygen species (ROS) such as H2O2, 
which oxidize cysteine residues and subsequently inhibit protein tyrosine phosphatases (PTPs)
32
. 
These reactive oxygen species have also been shown to enhance the Src activity
27, 33, 34
. This 
combined effect of phosphatase inhibition and Src kinase activation by growth factor receptors 
and ROS can highlight Src phosphorylation efficiency on the biosensors causing their FRET 
change. Hence, the differential Src activation at different compartments of the plasma membrane 
was then examined using a ROS generator pervanadate (PVD, 20 µM), which inhibits tyrosine 
phosphatases and activates Src kinase
33
. Again, the KRas-Src biosensor in HeLa cells showed a 
much faster and stronger FRET change in comparison to the Lyn-Src biosensor (Fig. 3-4A). The 
CFP/YFP ratio of Lyn-Src biosensor starts to increase around 15 min after PVD application 
when that of KRas-Src biosensor had already reached its peak. These significantly distinct time 
courses in FRET response of the KRas- and Lyn- Src biosensors suggest that raft- and non-raft-
associated proteins are possibly separated or exchangeable but stay at the different microdomains 
with different resident time
15, 35
. Similar difference in the responses of the KRas- and Lyn-Src 
biosensors was also observed in other cell types, including bovine aortic endothelial cell (BAEC) 
and mouse embryonic fibroblast (MEF) (Fig. 3-5). These PVD-induced FRET changes of Src 
biosensors were inhibited in SYF-/- MEF cells (null in Src family kinases, Src, Yes, and Fyn) or 
after the pretreatment of Src inhibitor PP1 (20 µM) in HeLa cells (Fig. 3-6), confirming that the 
PVD-induced FRET responses mainly represent the enhanced Src activities. These results 
suggest that a faster and stronger enhancement of Src activity occurred in non-raft regions at the 
plasma membrane.  
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Quantification of the kinetics and magnitude of the FRET responses of Src biosensors 
To further study the different kinetics of the Src phosphorylation efficiency upon PVD in 
membrane compartments, the parameters representing the Src activation kinetics based on the 
velocity curves of FRET change in time were quantified (Fig. 3-7). The velocity of FRET change, 
vi, was calculated by taking the discrete time derivatives of the normalized CFP/YFP emission 
ratios. The resulting bell-shaped velocity curves were fitted by the Gaussian functions given by 
the equation, 
 
 
 
The parameters A,  , and  , were estimated by parameter fitting to represent the total 
FRET change, reaction duration, and the time point where the reaction reaches the maximal 
velocity, respectively. The onset time of the reaction, T0, was calculated based on the values of 
  and   (T0 = -1.64485 , see Materials and Methods section). The mean and standard 
deviation of the parameters were calculated using data from multiple cells and compared 
between different groups. 
The KRas-Src biosensor, in comparison to the Lyn-Src biosensor, showed significantly 
higher value in A (KRas-Src: 0.5734 ± 0.0122; Lyn-Src: 0.3381 ± 0.0088), representing a 
stronger response, and lower values in   (KRas-Src: 2.058 ± 0.1169; Lyn-Src: 2.441 ± 0.1459) 
and T0 (KRas-Src: 6.936 ± 0.6320; Lyn-Src: 14.042 ± 0.1942), indicating faster and quicker 
responses (Fig. 3-7). These statistical results confirmed the FRET observations obtained from 
single-cell imaging. The different dynamics of compartment-targeted Src biosensors was further 
verified by immunoprecipitation/immunoblotting. As shown in Fig. 3-8, the phosphorylation of 
the KRas-Src biosensor caused by the enhanced Src activity was detected earlier than that of the 
Lyn-Src biosensor upon PVD stimulation.  
 
Inducible heterodimerization system  
The membrane-anchoring motif for the Lyn-Src biosensor is at the N-terminus whereas it 
is at the C-terminus for the KRas-Src biosensor (Fig. 3-1). To exclude the possibility that 
different responses of biosensors were caused by different tagging motifs or 3D orientations of 
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the biosensors in relation to the plasma membrane, an inducible heterodimerization system for 
the membrane localization was applied
36
 (Fig. 3-9A). The cytosolic Src biosensor was fused to 
the FRB domain, and the Lyn- or KRas-targeting motif was fused to FKBP (FRB binding 
peptides) (Fig. 3-1).  
When a heterodimerizer AP21967 (1 µM) was introduced into HeLa cells expressing 
FRB-Src biosensor and the Lyn- or KRas-FKBP peptide, the cytosolic FRB-Src biosensor was 
successfully recruited to the Lyn- or KRas-FKBP peptides located at the plasma membrane (Fig. 
3-9B, Data not shown). Again, the subsequent addition of PVD induced a faster and stronger 
FRET response of the FRB-Src biosensor dimerized with KRas-FKBP than that with Lyn-FKBP 
(Fig. 3-10). Statistical results further revealed that the KRas-FKBP/FRB-Src biosensor has 
higher A and lower   values, in comparison to the Lyn-FKBP/FRB-Src biosensor (Fig. 3-10). 
These results verified that the different kinetics of KRas- and Lyn-Src biosensors originate from 
their differential compartmental localization, but not from different tagging motifs, nor 3D 
orientations.  
 
Two distinct populations of Src kinases are regulated by different cytoskeletal components 
The plasma membrane is directly connected with and mechanically supported by 
cytoskeletal structures such as polymerized actin and microtubule filaments
4, 37 , 38
. The 
cytoskeleton has also been known to play important roles in the intracellular movement of 
molecules, in particular, Src translocation
8, 14
. Thus, I examined the role of the cytoskeletal 
network in regulating the localization and activation of Src kinase at different membrane 
compartments. 
Since it has been shown that Src kinase can be transported to the plasma membrane via 
the actin network upon growth factor stimulation
31
, I monitored the mobilization of Src kinase 
(Fig. 3-11A) and actin dynamics upon PVD application (Fig. 3-11B) using EGFP-conjugated c-
Src kinase
8
 and mCherry-conjugated β-actin26. At the resting state, a large population of Src 
kinases can be clearly observed near perinuclear region within endosome-like structures as 
previously reported
8
. At 10 min after PVD application, the Src concentration started to decrease 
in perinuclear regions, with a concomitant increase at cell periphery and plasma membrane 
ruffles. A co-localization of Src kinase and actin can also be observed at the cell periphery 
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regions after PVD stimulation (Fig. 3-11, indicated as red arrows). These results suggest that Src 
kinase may be transported to plasma membrane by actin filaments upon PVD stimulation. Indeed, 
after the pretreatment of cytochalasin D (CytoD) for 1 hr to block actin polymerization, the 
redistribution of EGFP-wt Src upon PVD was not observed (Fig. 3-12A). The membrane-
translocation of Src kinase was also blocked by co-transfection of Scar1 WA (a dominant 
negative mutant of Scar1), which inhibits actin nucleation (Fig. 3-12B). Interestingly, the 
inhibition of microtubule by nocodazole (Noco) did not significantly affect the redistribution of 
c-Src kinase into cell peripheral regions (Fig. 3-12C). These results suggest that Src kinases can 
translocate to the plasma membrane by utilizing the actin cytoskeleton upon PVD stimulation, 
similar to previous observations in cells subjected to growth factor stimulation
31
. 
I then investigated the relationship between different cytoskeletal networks and the 
responses of Src biosensors (Fig. 3-13 and 3-14). The PVD-induced FRET response of the Lyn-
Src biosensor was significantly inhibited by 1 hr of pretreatment with CytoD (1 M), but not 
with Noco (1 M) (Fig. 3-13). CytoD increased the duration of the reaction (  increased from 
2.441 ± 0.1459 to 4.474 ± 0.4830) and decreased total FRET change (A decreased from 
0.3381±0.0088 to 0.2049 ± 0.0366) of the Lyn-Src biosensor, suggesting a slower and weaker 
response (Fig. 3-13C and D).  In contrast, no such difference in the kinetics of Src activation was 
observed in Noco-treated group (Fig. 3-13C and D). These results suggest that the PVD-induced 
Src activation at lipid rafts is dependent on actin, likely through the Src translocation to the 
plasma membrane mediated by actin, but not microtubules. 
In contrast to the Lyn-Src biosensor, the PVD-induced rapid response of the KRas-Src 
biosensor was independent of the membrane-translocation of perinuclear Src kinases. The 
disruption of actin filaments, which blocked the membrane-translocation of Src kinase (Fig. 3-
11), did not show significant inhibitory effects on the response of the KRas-Src biosensor (Fig. 
3-14). In fact, the KRas-Src biosensor started to respond at around 5 min (Fig. 3-4B), well before 
a significant translocation of Src kinases can be observed (Fig. 3-11). Interestingly, the non-raft 
Src activity was dependent on microtubules, because the pretreatment with Noco caused a 
significantly delayed (T0 increased from 6.936 ± 0.6320 to 14.263±0.9240) and slower (  
increased from 2.058 ± 0.1169 to 5.023 ± 0.7430) response of the KRas-Src biosensor upon PVD 
treatment (Fig. 3-14C and D). Taxol, a reagent stabilizing microtubules and hence perturbing the 
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dynamics of microtubules, showed similar effects as Noco on the non-raft KRas-Src biosensor 
(Data not shown). The total change of CFP/YFP ratio A for the KRas-Src biosensor was not 
significantly affected by Noco treatment (Fig. 3-14C and D), suggesting that microtubule may 
affect the onset time and speed, but not the total magnitude of the non-raft Src activation.  
I have further conducted the experiments on the roles of microtubules and actin 
cytoskeleton on the responses of the cytosolic Src biosensor. The results revealed that the 
disruption of neither actin cytoskeleton nor microtubules inhibited the FRET response of 
cytosolic Src biosensor upon PVD stimulation (Data not shown). These results suggest that the 
inhibitory effect of cytoskeletal disruption is specific for the membrane-targeted biosensors and 
that the induced phosphorylation of Src biosensor by Src kinase in the cytoplasm does not 
require an intact cytoskeleton upon PVD. Thus, the cytoskeleton may be important for the 
regulation of Src functions at the plasma membrane, but not necessary so for the cytosolic 
processes.   
 
 
Discussion 
 
Proper subcellular localization of signaling molecules and interaction with correct target 
molecules are important characteristics of coordinated regulation of the complex signaling 
network and physiological functions. For example, Src induces the p190GAP activation and 
inhibits Rho GTPase at the focal adhesion sites
6
, whereas it activates Rho GTPase at podosomes
9
. 
Lipid rafts have been suggested to serve as the integration site for a variety of signaling pathways. 
The localization of small GTPase TC10 at lipid rafts is required for the insulin-induced 
activation and the subsequent regulation of glucose transporter (GLUT) 4
39
. Akt in or outside of 
lipid rafts responded differently to PDGF but not to IGF-1
40
. Src kinase also appears to be 
recruited into lipid rafts by Cbp and inhibited by Csk
41
. Due to the controversial effects of 
detergent-based extraction of rafts-associated proteins, contradictory results have been reported 
on the roles of rafts or membrane compartments in determining the Src functions
16-21
.  
In this chapter, I developed a novel non-invasive method, combining FRET biosensor 
with targeting signals and statistical analysis, to study the Src activity in live cells at different 
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compartments of plasma membrane. The results indicate that the Src activity at the plasma 
membrane outside of lipid rafts is enhanced in a faster and stronger fashion upon growth factors 
and PVD. Together with the previous observations that, at resting state, Src kinase is 
concentrated at the plasma membrane outside of DRM regions
16, 18, 20
 and at cytoplasm in 
perinuclear endosomes
8, 14
, our results support the model of two distinct populations of Src (Fig. 
3-15). One population of Src kinase exists in non-raft regions on the plasma membrane at the 
resting state and can be rapidly activated upon stimulation
16, 18, 20
. The other population of Src is 
located in perinuclear endosomes at the resting state, and can be transported to lipid rafts upon 
stimulation in an actin-dependent manner. These differentially regulated Src may direct different 
cellular functions. Indeed, v-Src at different subcellular locations has been recently reported to 
regulate differential signaling pathways. For example, v-Src was found at both raft and non-raft 
regions upon thermoactivation to regulate PI3K/Akt and MAPK/ERK pathways, respectively
42
. 
In fact, the raft-anchored Akt biosensor has been recently shown a faster and stronger response 
upon PDGF stimulation than that in non-raft regions
40
, suggesting that the raft-localization 
facilitates the Akt activation. Together with our observations that Src kinase functions more 
strongly in non-raft regions at the plasma membrane, it is clear that cells can coordinate the 
molecular functions and network by controlling the subcellular localization of molecules. 
The results in this chapter further suggest that these distinct responses of membrane-
targeted Src biosensors are mediated by different cytoskeletal networks. The disruption of 
microtubules had significant effects on the early non-raft Src activation without affecting the 
translocation and activation of Src at rafts (Fig. 3-12 and 3-14), whereas the blockade of actin 
polymerization by CytoD significantly inhibited the membrane translocation of Src and its 
activity at lipid rafts (Fig. 3-12 and 3-13). Although there is a possibility that the inhibited 
activation of Lyn-Src biosensor may not be solely due to the blockage of Src translocation 
because actin depolymerization may also affect other cellular processes, the results suggest the 
model that Src activation at rafts may be dependent on the transportation of Src kinases from 
perinuclear regions to the plasma membrane by actin cytoskeleton. This model is supported by 
the previous observation that Src can be transported from perinuclear endosome-like regions to 
cell membrane via actin cytoskeleton and becomes highly activated
8
. In fact, there is ample 
evidence that lipid rafts are closely connected to actin cytoskeleton. For example, actin-binding 
proteins such as ezrin and filaminA can serve as bridges between actin cytoskeleton and raft-
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associated protein such as PAG1 and CD28
43
. The raft-associated phosphoinositide lipid 
PI(4,5)P2 was also shown to regulate actin dynamics by recruiting actin-regulatory molecules 
such as WASP and ERM
44
. Indeed, actin depolymerization by Latrunculin B blocks the proper 
localization and simulation-induced clustering of raft-anchored fluorescent probes or H-Ras 
molecules
45, 46
. The treatment of CytoD to disrupt actin filaments also prevented proper 
interactions between raft-associated Lyn and IgE-FcRI47. 
Interestingly, a negative mutant of Scar1 (WA) blocked the responses of both KRas- and 
Lyn-Src biosensor upon PVD (Data not shown). We reasoned that there may be a slow chronic 
recycling process to maintain the pre-stored Src population at the plasma membrane outside of 
lipid rafts
48
, which is dependent on actin-mediated membrane-transportation. The long-term (48 
hr) inhibition of actin nucleation by Scar1 WA may block the membrane-transportation and 
prevent an accumulation of Src at the plasma membrane in and outside of lipid rafts, resulting in 
the inhibition of both the Lyn- and KRas-Src biosensors. It is possible that Src kinases are 
initially transported to lipid rafts and then translocate into non-raft regions to form the pre-stored 
Src population. The short-term (1 hr) treatment of CytoD may only block the acute membrane-
translocation of Src toward lipid rafts, but did not affect the pre-stored Src outside of lipid rafts. 
Hence, CytoD significantly inhibited the response of Lyn-Src, but not that of KRas-Src biosensor 
(Fig. 3-13 and 3-14).  
In contrast to the traditional in vitro assays performed in test tubes and cuvettes, the 
integration of FRET biosensors with specific membrane-targeting signals allows the 
quantification of the parameters of enzymatic reactions such as T0, A, and   in compartments of 
plasma membrane, whose sizes are smaller than the resolution of conventional optical 
fluorescence microscope (e.g. the size of single lipid raft is believed to be around 50 nm)
49
. The 
velocity of FRET response in the membrane compartment of each individual cell fits well with 
the bell-shaped Gaussian function. This result indicates that enzymatic reactions in these 
different compartments are relatively complex and different from the instant-onset enzymatic 
reaction described by the Michaelis–Menten model in vitro. These FRET analysis assays can 
hence advance our systematic and in-depth understanding of enzymatic reactions at subcellular 
compartments in live cells. The curve fitting and statistical analysis method also provides a 
general platform to integrate a large quantity of data from single-cell FRET images for the 
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quantification of the molecular kinetics of different signaling cascades. In combination to this 
statistical analysis approach, the FRET biosensors and live-cell imaging techniques can provide a 
robust and non-intrusive alternative to the biochemical assays.  
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Figures 
 
 
 
Figure 3-1. Schematic diagram for DNA constructs.  
KRas-Src biosensor was developed by introducing prenylation sequences from KRas to the C-
termini of the Src biosensor. Lyn-Src biosensor was constructed by genetically fusing an 
acylation substrate sequence derived from Lyn kinase to the N-termini of the Src biosensor. 
FRB-Src biosensor was constructed by fusing FRB domain in N-termini of Src biosensor. KRas 
and Lyn sequences were added in C- and N-termini of FKBP domains to generate membrane-
targeted domains KRas-FKBP and Lyn-FKBP, respectively.  
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Figure 3-2. The representative images of differential interference contrast (DICIII), 
fluorescence channels of ECFP and EYFP for KRas-Src (upper), Lyn-Src (middle), and 
FRB-Src (lower) biosensors. 
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Figure 3-3. Differential responses of the Src biosensor tethered at different 
compartments of the plasma membrane upon growth factor stimulations.  
The CFP/YFP emission ratio images of KRas- (upper panels) or Lyn-Src biosensors (lower 
panels) in response to 50 ng/ml of (A) EGF in HeLa cells or (B) PDGF in MEF cells. The scale 
bars on the left of the images represent the levels of CFP/YFP emission ratio. Time courses on 
the right panels represent the normalized CFP/YFP emission ratio of KRas- (purple) and Lyn-
Src biosensors (green) before and after stimulations.  
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Figure 3-4. Differential responses of the KRas- and Lyn-Src biosensors upon 
pervanadate  stimulation. 
(A) The CFP/YFP emission ratio images of HeLa cells with KRas- or Lyn-Src biosensors in 
response to 20 µM of pervanadate (PVD). (B) Time courses of the the normalized CFP/YFP 
emission ratio of KRas- (purple) and Lyn-Src biosensors (green) before and after PVD 
stimulations.  
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Figure 3-5. PVD-induced differential responses of the KRas- and Lyn-Src biosensors in 
BAEC and MEF cells. 
Time courses of CFP/YFP emission ratio of KRas- (purple) and Lyn-Src biosensors (green) 
upon PVD application in (A) BAEC and (B) MEF cells.  
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Figure 3-6.  PVD-induced FRET level changes of KRas- and Lyn-Src biosensors are 
inhibited by Src inhibitor PP1 or in Src knock-out cells. 
(A) The values (mean±SEM) of the normalized CFP/YFP ratio of KRas-Src (at 15 min when the 
response of the KRas-Src biosensor is maximal, purple bars) and Lyn-Src biosensors (at 20 min 
when the response of the Lyn-Src biosensor is maximal, green bars) upon PVD application with 
(+pp1) or without (Control) the pretreatment of PP1 (20 μM, 1 hr). Asterisks indicate significant 
differences (p < 0.05) between different groups (n = 3-11). (B) The peak values (mean ± SEM) 
of the normalized CFP/YFP ratio of KRas-Src (at 15 min, purple bars) and Lyn-Src biosensors 
(at 20 min, green bars) upon PVD application in MEF cells (Control) or SYF-/- MEF cells (SYF-/-
). Asterisks indicate significant differences (p < 0.05) between different groups (n = 3-6).  
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Figure 3-7. Quantification of the kinetics and magnitude of the PVD-induced FRET 
responses of Src biosensors  
(A) The representative velocity curves of FRET signals of KRas- (purple) and Lyn-Src 
biosensors (green) upon PVD application. Solid lines represent curves of Gaussian function 
determined by curve-fitting. (B) The normalized values (mean ± SEM) of T0, σ and A for KRas- 
(black bar) and Lyn-Src biosensors (white bar) determined by parameter fitting (n=11 and 8, 
respectively). Asterisks indicate significant differences (p < 0.05) between different groups. (C) 
The values (mean ± SEM) of parameters T0, σ and A for KRas- or Lyn-Src biosensors. KRas 
biosensor: n=11, average R2=0.87, Lyn biosensor: n=8, average R2=0.83.  
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Figure 3-8. The levels of phosphorylated tyrosine in KRas- (upper panels) or Lyn-Src 
biosensors (lower panels) upon PVD application.  
Src biosensors were immunoprecipitated (IP) from HeLa cells and immunoblotted (IB) for the 
tyrosine phosphorylation (pY) level. The expressed protein (GFP) levels of the biosensors were 
also shown to indicate that the loaded protein amounts are similar among different groups.  
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Figure 3-9. The responses of Src biosensors tethered at the plasma membrane through 
heterodimerization system. 
(A) A cartoon scheme depicting compartmentalization of the biosensors to the plasma 
membrane by an inducible heterodimerization system. (B) The CFP images of FRB-Src 
biosensor before and after AP21697-induced dimerization with Lyn-FKBP.  
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Figure 3-10. The responses of Src biosensors tethered at the plasma membrane through 
heterodimerization system. 
(A) The CFP/YFP emission ratio images of FRB-Src biosensor dimerized with KRas-FKBP or 
Lyn-FKBP before and after PVD application for various periods of time. (B) Time courses of 
CFP/YFP emission ratio of FRB-Src biosensors fused to KRas-FKBP (purple) or Lyn-FKBP 
(green) upon PVD application in HeLa cells. (C) The values (mean ± SEM) of parameters T0, σ 
and A for indicated groups of KRas- or Lyn-Src biosensors. KRas-FKBP & FRB-Src: n=3, 
average R2=0.61, Lyn-FKBP & FRB-Src: n=3, average R2=0.27.  
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Figure 3-11. Src can translocate to plasma membrane via actin cytoskeleton. 
Images of EGFP-conjugated c-Src kinase (A) and mCherry-conjugated actin (B) before and 
after PVD stimulation for various periods of time. Red arrows point to the membrane ruffles 
where Src kinase and actin fibers are colocalized. 
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Figure 3-12. The distribution of EGFP-conjugated c-Src kinase in HeLa cells before and 
after PVD application  
(A) Cytochalasin D pretreated group, (B) Scar1 WA co-transfected group, (C) Nocodazole 
pretreated group.  
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Figure 3-13. PVD-induced Src biosensor responses at lipid rafts of the plasma membrane 
was inhibited by CytoD, but not by Nocodazole. 
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Figure 3-13. PVD-induced Src biosensor responses at lipid rafts of the plasma membrane 
was inhibited by CytoD, but not by Nocodazole. 
(A) The CFP/YFP emission ratio images of HeLa cells expressing Lyn-Src biosensors. The cells 
were exposed to 20 μM of PVD after pretreatment of CytoD or Noco as indicated.  
(B) The representative velocity curves of FRET change in indicated groups of Lyn-Src 
biosensors upon PVD application. Lines show the curves of Gaussian function determined by 
curve-fitting. Black closed circles and solid lines represent control groups of the biosensors as 
indicated, grey closed circles and solid lines are CytoD-pretreated groups, and opened circles 
and black dotted lines are Noco-pretreated groups.  
(C) Bar graphs represent the normalized values (mean ± SEM) of parameters T0, σ and A in 
different groups of Lyn-Src biosensors (n = 8-13). Black, grey and white bars represent results 
of biosensors in control cells, cells treated with cytochalasin D (CytoD) or nocodazole (Noco). 
Asterisks indicate significant difference with 95% confidence determined by Bonferroni test.  
(D) The values (mean ± SEM) of parameters T0, σ and A for Control, CytoD- or Noco-treated 
groups of Lyn-Src biosensors. Lyn Control: n=8, average R2=0.83, Lyn+CytoD: n=12, average 
R2=0.80, Lyn+Noco: n=13, average R2=0.78.  
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Figure 3-14. PVD-induced Src biosensor responses at non-raft regions of the plasma 
membrane was delayed by Nocodazole. 
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Figure 3-14. PVD-induced Src biosensor responses at non-raft regions of the plasma 
membrane was delayed by Nocodazole. 
(A) The CFP/YFP emission ratio images of HeLa cells expressing KRas-Src biosensors. The 
cells were exposed to 20 μM of PVD after pretreatment of CytoD or Noco as indicated. 
(B) The representative velocity curves of FRET change in indicated groups of KRas-Src 
biosensors upon PVD application. Black closed circles and solid lines represent control groups 
of the biosensors as indicated, grey closed circles and solid lines are CytoD-pretreated groups, 
and opened circles and black dotted lines are Noco-pretreated groups.  
(C) Bar graphs represent the normalized values (mean ± SEM) of parameters T0, σ and A in 
different groups of KRas-Src biosensors (n = 8-13). Black, grey and white bars represent results 
of biosensors in control cells, cells treated with cytochalasin D (CytoD) or nocodazole (Noco). 
Asterisks indicate significant difference with 95% confidence determined by Bonferroni test.  
(D) The values (mean ± SEM) of parameters T0, σ and A for Control, CytoD- or Noco-treated 
groups of KRas-Src biosensors. KRas Control: n=11, average R2=0.87, KRas+CytoD: n=13, 
average R2=0.84, KRas+Noco: n=13, average R2=0.74.  
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Figure 3-15. A proposed model of two distinct populations of Src kinases at plasma 
membrane.  
One population of Src kinases is pre-stored outside of lipid rafts on plasma membrane at rest 
state and can be rapidly activated upon stimulation. Another population of Src kinases is located 
in endosome-like structures around nucleus at rest state, which can translocate to lipid rafts 
through actin filaments upon stimulation and become activated.  
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CHAPTER 4 
DISTINCT FAK ACTIVATION MECHANISMS AT LIPID RAFTS BY 
CELL ADHESION AND GROWTH FACTOR STIMULATION 
 
Proper subcellular localization of focal adhesion kinase (FAK) is crucial for many 
cellular processes, e.g. cell adhesion and migration. It remains, however, unclear how FAK 
activity upon various physiological stimulations is regulated at subcellular compartments of the 
plasma membrane. To visualize the FAK activity at different membrane microdomains, a 
fluorescence resonance energy transfer (FRET)-based FAK biosensor was developed and 
targeted into or outside of lipid rafts at the plasma membrane by lipid modifications. The results 
in this chapter showed that, upon cell adhesion on extracellular matrix proteins or stimulation by 
platelet-derived growth factor (PDGF), the FRET responses of lipid rafts-targeting FAK 
biosensor are surprisingly stronger than that of non-raft regions, suggesting that the FAK 
activation can occur at lipid rafts microdomains. Further experiments revealed that the PDGF-
induced FAK activation is mediated and maintained by the kinase activity of Src, whereas FAK 
activation by cell adhesion is independent of, and in fact essential for the Src activation. 
Therefore, these results suggest that FAK is activated at membrane microdomains with distinct 
activation mechanisms in response to different physiological stimuli. 
  
 
Introduction 
 
Focal adhesion kinase (FAK) localizes at focal adhesions upon integrin clustering to 
regulate cell adhesion, migration, and mechanotransduction
1-3
. In addition to its crucial roles in 
the integrin-mediated signaling cascades, FAK regulates cell migration and proliferation in 
response to growth factors
4
. Since FAK undergoes the association with membrane signaling 
proteins, i.e. integrins and growth factor receptors, it is expected that FAK is regulated and 
activated at the plasma membrane. It has been proposed that plasma membrane contains 
microdomains lipid rafts enriched with saturated fatty acids and cholesterol
5
, and due to their 
insolubility to nonionic detergents, e.g. Triton X-100, these membrane microdomains are often 
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referred as detergent-resistant membrane (DRM)
5, 6
. Although the physical structure of these 
microdomains is not fully characterized due to technical limitations, recent evidence suggests 
that different microdomains at the plasma membrane function as segregated signaling platforms. 
For example, the kinetics of Src activation, in response to growth factors and pervanadate, was 
different in and outside lipid rafts
7
; Different regulation of Akt was also observed in different 
membrane microdomains
8
. However, it remains unclear how FAK activation is regulated at 
different microdomains at the plasma membrane. In addition, the molecular signaling hierarchy 
governing FAK activation at these subcellular microdomains remains elusive. The traditional 
detergent extraction method to study molecular signals at membrane microdomains is based on 
the detergent-resistant property of DRM fractions. However, protein solubility can be changed 
during detergent treatment, thus the isolated DRM fractions may not correspond to those 
microdomains in living cells and indeed may originate from other membrane fractions
6, 9
. In 
particular, because these microdomains are structurally dynamic
5
, this traditional method is not 
sufficient to detect signaling events with high spatiotemporal resolution in live cells. Thus, new 
methods in visualizing FAK activities at membrane microdomains in live cells are of great 
interests to elucidate the innate FAK functions at these sub-membrane locations.   
To visualize subcellular molecular events in live cells, genetically-encoded biosensors 
based on fluorescent proteins (FPs) and fluorescence resonance energy transfer (FRET) have 
been developed
10
. Recently, two FRET-based FAK reporters have been independently developed 
to detect the conformational change of FAK
11, 12
. In both reporters, FRET donor FP was fused at 
the N-terminus of FAK, and acceptor FP was inserted at the linker region between the FERM 
and kinase domain of FAK. Despite their similar design strategies, the FRET responses of these 
two reporters upon FAK activation were opposite to each other: increasing in one case
12
 while 
decreasing in the other
11
. These observations suggest a complex and unclear FRET mechanism 
of these reporters. The inserted FP at the linker regions may also partially expose the kinase 
domain, causing an elevated enzymatic activity of the reporters comparing to the endogenous 
FAK
11
. This may introduce another layer of complexity when the reporters are expressed in the 
host cells, possibly by introducing extra enzymatic activity of FAK
11
. Another system consisting 
of FRET donor and acceptor FPs separately fused to FAK and a double-SH2 domain, 
respectively, was developed to report the FAK phosphorylation
11
. However, it is difficult to 
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determine whether the FRET signals in this case are engendered from the binding of the double-
SH2 domain to the phosphorylated Tyr397 or other tyrosine sites in FAK. Furthermore, because 
the acceptor/donor ratio at various subcellular locations is not uniform due to the different 
expression and localization of donors/acceptors, this approach requires more sophisticated 
mathematical methods to quantify the signals than a simple donor/acceptor ratio.  
In this chapter, a novel FRET-based FAK biosensor was developed to specifically detect 
the autophosphorylation at Tyr397 and its subsequent binding to the SH2 domain of Src, which 
are the crucial molecular events in FAK activation and thus represent the FAK activity
13
. An 
improved FRET pair, ECFP and YPet, was utilized to enhance the sensitivity of the biosensor
14
.  
To monitor the FAK activities at different microdomains of the plasma membrane, this FAK 
biosensor was further targeted in and outside lipid rafts through lipid modifications, e.g. 
acylation and prenylation
15
. The results showed that the FAK activity at lipid rafts was 
significantly higher than at non-raft regions upon either integrin-mediated adhesion or PDGF 
stimulation. Further results indicate that the PDGF-induced FAK activation at lipid rafts is 
regulated by Src kinase activity. In contrast, the adhesion-induced FAK activation is upstream to 
the Src activation. These results suggest that lipid rafts microdomains can serve as subcellular 
platforms for the proper FAK activation, which is involved in distinct molecular hierarchies in 
response to different physiological stimulations.  
 
 
Materials and Methods 
 
DNA constructions  
The cytosolic FAK biosensor (Cyto-FAK) was constructed by fusing the SH2 domain 
from c-Src, a flexible linker (GSTSGSGKPGSGEGS), and a FAK substrate peptide 
(ETDDYAEIIDE) between the N-terminus ECFP and the C-terminus YPet. The FAK (YF) and 
(RV) mutant biosensors were generated by site-specific mutations on the consensus tyrosine site 
(Y397F) in the substrate peptide and the critical arginine site (R175V) in the SH2 domain, using 
the QuickChange method (Stratagene). Lyn-FAK biosensor was constructed by adding a raft-
targeting motif (MGCIKSKRKDNLNDDE) derived from Lyn kinase to the N-terminus of the 
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Cyto-FAK biosensor
15
. KRas-FAK biosensor was constructed by adding a non-raft-targeting 
motif (KKKKKKSKTKCVIM) derived from KRas to the C-terminus of the Cyto-FAK 
biosensor
15
. The DNA encoding the FAK biosensors were subcloned with the BamHI/EcoRI 
sites in pRSetB for the protein purification from Escherichia coli, and in pcDNA3 plasmid for 
the expression in mammalian cells.  
The plasmids used in this study include the wild-type full-length FAK (FAK WT), the 
kinase-dead FAK with its kinase domain mutated (FAK KD), the C-terminal tail of FAK with 
the 1-375 amino acids truncated from the full-length FAK (FAK 1-375), the N-terminal tail 
(containing the 1-400 amino acids) of FAK (FAK NT), and the wild-type full-length of Src 
kinase (Src WT)
16, 17
.  
Lyn-Src FRET biosensor based on ECFP/YPet was generated by adding the raft-targeting 
motif to the Src biosensor
14
. The GFP-tagged Akt-PH, which can bind to PIP3 (a product of PI3K 
activity) and translocate to the plasma membrane upon PI3K activation, was applied as an 
indicator to monitor PI3K activity
14, 18
. 
 
Cell culture and reagents 
Mouse embryonic fibroblasts (MEFs) and FAK-/- MEF cells were maintained in 
Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 
2 mM L-glutamine, 1 unit/ml penicillin, 100 g/ml streptomycin, and 1 mM sodium pyruvate. 
Cell culture reagents were purchased from GIBCO BRL. Cells were cultured in a humidified 95% 
air, 5% CO2 incubator at 37C. Lipofectamine 2000 (Invitrogen) was used for the transfection of 
DNA plasmids.  
Platelet-derived growth factor (PDGF), fibronectin (FN), and methyl-β-cyclodextrin 
(MβCD) were purchased from Sigma. Src inhibitor PP1 was obtained from BioMol, and PI3K 
inhibitor LY294002 was purchased from CalBiochem. A specific FAK inhibitor PF573, 228 
(PF228)
19
 was obtained from Pfizer.  
 
Protein expression  
The FAK biosensors were in general expressed in Escherichia coli (BL21 strain) as 
fusion proteins with an N-terminal 6x His tag and purified by nickel chelation chromatography
17
. 
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Because KRas-FAK biosensor was severely cleaved when purified from BL21 cells, it was 
expressed in Rosetta 2 competent cells (Novagen) and purified by gel filtration on a Superdex 
200 PG column (16 mm × 620 mm). In brief, Rosetta 2 cells expressing KRas-FAK in the 
pRSETb vector were grown in LB medium (2l) containing ampicillin (100 mg/L) and 
chloramphenicol (25 mg/L) at 37 °C with shaking at 250 rpm until OD600 measured around 1.0. 
Isopropyl-β-D-thiogalactopyranoside (IPTG) was then added to a final concentration of 0.2 mM, 
and the culture was incubated for another 13 hours at 16 °C with shaking at 200 rpm.  Cells were 
harvested by centrifugation, and re-suspended in 20 ml binding buffer (20 mM Tris·HCl, 0.5 M 
NaCl, 5 mM imidazole, 10% glycerol, pH 7.9) and lysed by sonication.  The cell lysate was 
clarified by centrifugation before being applied to a 5 mL HiTrap Chelating HP column (GE 
Healthcare) at 4°C.  The column was washed sequentially with 50 ml binding buffer, 50 ml wash 
buffer 1 (20 mM Tris·HCl, 0.5 M NaCl, 50 mM imidazole, 10% glycerol, pH 7.9), and 25 ml 
wash buffer 2 (20 mM Tris·HCl, 0.5 M NaCl, 75 mM imidazole, 10% glycerol, pH 7.9).  The 
column was then eluted with 25 ml elution buffer (20 mM Tris·HCl, 0.5 M NaCl, 200 mM 
imidazole, 10% glycerol, pH 7.9). The eluted protein was further purified by gel filtration on a 
Superdex 200 PG column (16 mm × 620 mm) into kinase buffer (50 mM Tris·HCl, 100 mM 
NaCl, 10 mM MgCl2, pH 8). 
 
In vitro spectroscopy  
Fluorescence emission spectra of the purified biosensors were measured with an 
excitation wavelength of 430 nm by a fluorescence plate reader (TECAN, Sapphire II). The 
emission ratios of donor/acceptor (478 nm/526 nm) were measured before and after the addition 
of 1 mM ATP and recombinant FAK (1 g/ml) or Src kinase (1 g/ml, Upstate) in kinase buffer 
(50 mM Tris·HCl, 100 mM NaCl, 10 mM MgCl2, 2 mM DTT, pH 8)
17
. 
 
Immunoprecipitation and immunoblotting 
To examine the specificity of the FAK biosensor, different FAK biosensors (wild-type 
and mutants) were transfected into FAK-/- MEF cells expressing the control vector, Src, FAK, or 
the FAK mutants. After 48 hr of transfection, cell lysates from the various samples were 
subjected to immunoprecipitation with an anti-GFP antibody (Abcam) to pull down the biosensor 
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proteins, followed by the immunoblotting with an anti-phospho-tyrosine antibody (pY20, Santa 
Cruz Biotechnology, 0.2 µg/ml) to show the tyrosine phosphorylation level, or with an anti-GFP 
antibody (Santa Cruz Biotechnology, 0.2 µg/ml) to show the expressed protein levels.  
The phosphorylation levels on Tyr397 and the total protein levels of the endogenous 
FAK were measured by a specific anti-phospho Tyr397 antibody (BD Transduction, 0.2 µg/ml) 
and an anti-FAK antibody (Santa Cruz Biotechnology, 0.2 µg/ml), respectively. Antibodies to 
detect PDGFR, ERK phosphorylation, and ERK2 were purchased from Santa Cruz 
Biotechnology. 
 
Sucrose density gradient fractionation 
MEFs expressing the Lyn- or KRas-FAK biosensor were lysed with TNE buffer (10 mM 
Tris, pH 7.4, 150 mM NaCl, and 5 mM EDTA) containing 2 mM PMSF, 2 mM NaF, 2 mM 
NaVO4, 10 nM Caluculin A, and protease inhibitor cocktail tablet. The cell lysis was centrifuged 
at 5,000 rpm for 5 min at 4°C. The supernatant was collected and further centrifuged at 13,000 
rpm for 50 min at 4°C to obtain the membrane fractions of each group. These membrane 
fractions were gently reconstituted with 300 µl of lysis buffer containing 1% Triton X-100, and 
incubated on ice for 1 hr with periodic mixing. The samples were diluted with 300 µl of 85% 
sucrose solution, and layered by 1.2 ml of 35% sucrose, followed by additions of 300 µl of 5% 
sucrose solution and 1.35 ml of TNE buffer. Ultracentrifugation was performed at 200,200 g for 
18 h in a Beckman TL-100 rotor at 4°C. After ultracentrifugation, the top 1.05 ml sample was 
discarded. Nine 250 µl fractions were then collected, starting from the top of the gradient, and 
immunoblotted with an anti-GFP antibody (Santa Cruz Biotechnology, 0.2 µg/ml) to detect Lyn- 
and KRas-biosensors, with the Caveolin-1 antibody (sc-894, Santa Cruz Biotechnology, 0.2 
µg/ml) serving as a marker for membrane rafts regions. 
 
Image acquisition 
Cells were cultured in cover-glass-bottom dishes (Cell E&G) and maintained in CO2-
independent medium containing 0.5% FBS (Gibco BRL) at 37°C during imaging. Images were 
collected by a Zeiss Axiovert microscope and MetaFluor 6.2 software (Universal Imaging) with 
a 420DF20 excitation filter, a 450DRLP dichroic mirror, and two emission filters controlled by a 
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filter changer (475DF40 for ECFP and 535DF25 for YPet). The excitation filter for ECFP at 
420±20 nm was selected to shift toward lower wavelength away from the peak excitation spectra 
of ECFP to reduce the cross-excitation of YPet and the effect of bleed-through on the FRET 
channel. The whole cell bodies were selected as the regions of interests to collect signals and 
conduct quantification. In brief, the image analysis was conducted based on the customized 
software written in MATLAB (version R2008a, The MathWorks Inc., Natick MA). All the 
images were background-subtracted and smoothed using a median-filter with a window size of 
3x3 pixels. The FRET images of the FAK biosensor were utilized to compute the masks of the 
cells using the Otsu’s method where value 1 was assigned at the pixel location of cell body and 0 
outside
17
. The fluorescence intensity of non-transfected cells was quantified as the background 
signal and subtracted from the ECFP and YPet signals of transfected cells. The pixel-by-pixel 
ratio images of ECFP/YPet were calculated based on the background-subtracted fluorescence 
intensity images of ECFP and YPet by using the MetaFluor software. These ratio images were 
displayed in the intensity modified display (IMD) mode in which the color and brightness of 
each pixel is determined by the ECFP/YPet ratio and ECFP intensity, respectively. 
 
 
Results 
 
Design of FAK FRET biosensor and its characterization in vitro 
A FRET-based FAK biosensor was designed to contain the SH2 domain derived from c-
Src, a flexible linker peptide, and a specific substrate sequence from FAK encompassing Tyr397, 
concatenated between ECFP and YPet (Fig. 4-1A). It is expected that Tyr397 in the substrate 
peptide is phosphorylated by FAK (trans-activation) and subsequently binds to the 
intramolecular SH2 domain, causing a conformation change and a decrease in FRET (Fig. 4-1B). 
Fluorescence emission spectra of the purified FAK biosensors were measured with an excitation 
wavelength of 430 nm, and the emission ratios of donor/acceptor (478 nm/526 nm) were 
measured before and after the addition of 1 mM ATP and recombinant FAK (1 g/ml) in kinase 
buffer
17
 (Fig. 4-2A). Upon incubation with FAK, the ECFP emission of the FAK biosensor 
increased, while that of YPet decreased (Fig. 4-2A), suggesting an increase in the ECFP/YPet 
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ratio and hence a decrease in FRET. The quantified results further revealed that the ECFP/YPet 
emission ratio of the biosensor was strongly increased around 90% upon FAK incubation (Fig. 4-
2B). This FRET response was eliminated by a specific FAK inhibitor PF573,228 (PF228, 1µM), 
or a mutation of Tyr397 to Phe in the substrate peptide (FAK YF mutant) (Fig. 4-2B). These 
results suggest that the FRET change of the biosensor is due to the phosphorylation of the 
biosensor specifically by FAK, which was further confirmed by western blot analysis (Fig. 4-2C). 
Importantly, no FRET change of the biosensor was observed upon Src incubation (Fig. 4-2B), 
which was previously shown to cause significant FRET changes of Src FRET biosensors
14, 17
. 
These results suggest that the biosensor reports the FAK activity in vitro, but not that of Src, a 
kinase well-regarded to accompany and coordinate closely with FAK in many cellular events
20
.  
 
Characterization of the FAK biosensor in mammalian cells 
Next, I examined the FAK biosensor in mammalian cells. The ECFP/YPet emission 
ratios of the FAK biosensor were significantly higher in mouse embryonic fibroblasts (MEFs) 
adhered on fibronectin (FN) than those in suspension (Fig. 4-3), consistent with the knowledge 
that the integrin-mediated cell adhesion can induce FAK activation
1
. In contrast, no FRET 
change was observed in FAK-/- MEFs (Fig. 4-3), suggesting the specificity of the biosensor in 
reporting the FAK activity.  
To further examine its specificity, we introduced the FAK biosensor together with wild-
type FAK or its various mutants in FAK-/- MEFs, and measured the FRET levels in these cells 
adhered on FN (Fig. 4-4A, white bars). The constitutively active FAK (FAK 1-375)16 and wild-
type FAK (FAK WT) caused significantly higher ECFP/YPet emission ratios than the negative 
mutant of FAK (FAK NT)
16
, kinase-dead FAK (FAK KD), or empty vector. Consistent with the 
in vitro results (Fig. 4-2B), the expression of wild-type Src (Src WT) caused no significant FRET 
change of the FAK biosensor in FAK-/- cells. These results suggest that the FAK biosensor can 
specifically detect the adhesion-induced FAK activation in mammalian cells. The mutation of 
either the substrate Tyr397 to Phe (YF) or Arg175 to Val (RV) in the SH2 domain of the 
biosensor eliminated the FRET response of the FAK biosensor in FAK-/- cells expressing the 
active FAK 1-375 (Fig. 4-4A, black bars). These results verify the design strategy of FAK 
biosensor that the FRET response upon FAK activation is due to the intramolecular interaction 
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between the phosphorylated substrate and the SH2 domain. Consistently, strong phosphorylation 
was observed only in the groups where the wild-type biosensor was expressed together with 
FAK 1-375 or FAK WT (Fig. 4-4B). These results indicate that, in mammalian cells, the 
substrate tyrosine is specifically phosphorylated by FAK to result in the FRET change of the 
biosensor.  
 
The FAK activity at different microdomains of plasma membrane 
FAK can be activated at the plasma membrane which contains different microdomains. 
Recent evidence suggests that FAK can localize at lipid rafts microdomains
21
, and may regulate 
the subcellular localization of these membrane microdomains
22
. To observe the FAK activity at 
lipid rafts, Lyn-FAK biosensor was constructed by fusing a lipid rafts-targeting motif containing 
myristoylation and palmitoylation sites (glycine and cysteine) derived from Lyn, at the N-
terminus of the cytosolic FAK (Cyto-FAK) biosensor (Fig. 4-5A)
15
. In parallel, a polybasic-
geranylgeranyl motif (cysteine) adapted from K-Ras, was fused at the C-terminus of the Cyto-
FAK biosensor for the generation of KRas-FAK biosensor which can localize at the general 
membrane area outside of lipid rafts (Fig. 4-5A)
15
. The result of sucrose density gradient 
fractionation after the incubation with Triton-X, further confirmed that Lyn-FAK biosensor was 
detected in the detergent-resistant fraction marked by an endogenous DRM-indicator caveolin-1, 
whereas KRas-FAK biosensor appeared in the fraction representing the general membrane 
regions but excluded from DRM (Fig. 4-5B). Similar results have been reported to verify the 
correct localization of Lyn- and KRas-modified proteins
8, 15
. When the cysteine in Lyn- and 
KRas-tags, which is the major site for the lipid modifications, was mutated to serine, these 
Lyn(CS)- and KRas(CS)-FAK biosensors could not correctly localize at the plasma membrane 
(Fig. 4-6), suggesting that lipid modification is crucial for their subcellular localization at 
membrane microdomains. Therefore, these results suggest that Lyn- and KRas-FAK biosensors 
can be successfully targeted into different microdomains of the plasma membrane through 
different lipid modifications. 
I then examined the FAK activity at membrane microdomains upon cell adhesion on 
fibronectin. Lyn-FAK biosensor tethered at lipid rafts showed a significantly higher ECFP/YPet 
level comparing to KRas-FAK biosensor (Fig. 4-7A and B). The ECFP/YPet ratio of the Lyn-
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FAK biosensor, but not the KRas-FAK biosensor, decreased from 1.1 to 0.9 in adherent cells 
upon the incubation of the FAK inhibitor PF228 (Fig. 4-7C). The treatment of methyl-β-
cyclodextrin (MβCD), which can extract cholesterol and thus disrupt the microdomain structure, 
decreased the ECFP/YPet ratio of Lyn-FAK biosensor, but not KRas-FAK biosensor (Fig. 4-7D). 
These results suggest that FAK activity is higher inside lipid rafts than non-raft regions. The 
minimal response of KRas-FAK biosensor should be due to the lack of local FAK activity 
outside lipid rafts, but not the steric difficulty of KRas-tagged biosensor in undergoing 
conformational changes or the activation preference of PDGFR/integrins at lipid rafts, because 
KRas-Src biosensor, anchoring outside lipid rafts with the same targeting strategy as KRas-FAK 
biosensor, can be markedly activated upon cell adhesion (Fig. 4-8) or PDGF stimulation
7
. In 
vitro kinase assay further revealed that FAK can cause the similar FRET responses of the 
purified Lyn- and KRas-FAK biosensors (Fig. 4-9). Therefore, the different FRET responses of 
Lyn- and KRas-FAK biosensors in cells are not because of their different membrane-targeting 
tags but reflecting the differential local FAK activities at membrane microdomains.  
Although Lyn-FAK biosensor does not contain specific anchoring domain at focal 
adhesion (FA) sites, the ECFP/YPet ratios were higher at FAs upon adhesion (Fig. 4-10). In fact, 
the difference of ECFP/YPet ratios of Lyn-FAK biosensor in and outside FAs was significantly 
higher than that of KRas-FAK biosensor (Fig. 4-11). These results indicate that the FAK 
activation at FAs can be more correlated with lipid rafts and hence more efficiently visualized by 
Lyn-FAK biosensor.  
   
The PDGF-induced FAK activation at DRM regions 
I next investigated the FAK activation in and outside lipid rafts in response to PDGF 
stimulation. Lyn-FAK biosensor at lipid rafts showed 15-20% increase in ECFP/YPet ratio 
within 10 min of PDGF stimulation, whereas KRas-FAK biosensor had only a minimal FRET 
change (< 5%) (Fig. 4-12A and B). The negative mutant of Lyn-FAK (YF) biosensor also 
showed a minimal response (Fig. 4-12B), suggesting that the phosphorylation at the designed 
tyrosine site is responsible for the PDGF-induced FRET change. Biochemical western blot assay 
further confirmed that the Lyn-FAK biosensor phosphorylation showed a similar pattern as the 
Tyr397 phosphorylation of the endogenous FAK (Fig. 4-12C). PF228 reversed the PDGF-
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induced FRET response of Lyn-FAK biosensor (Fig. 4-13A) without any effect on the PDGFR 
phosphorylation (Fig. 4-13C), verifying the high specificity of the biosensor in reporting the 
PDGF-induced FAK activation. The PDGF-induced FRET signal of Lyn-FAK biosensor was 
also suppressed by MβCD (Fig. 4-13B), confirming the localization and functionality of Lyn-
FAK biosensor at lipid rafts. 
 
Src activity is required for the PDGF-induced FAK activation 
Previous studies showed that, in response to PDGF, FAK can associate with Src
4
 and 
PI3K
23
 to regulate downstream signaling cascades and cellular processes. I first investigated the 
molecular hierarchy regulating FAK and Src activations at lipid rafts in response to PDGF. PP1, 
a Src kinase inhibitor, completely blocked the PDGF-induced FRET response of Lyn-FAK 
biosensor (Fig. 4-14). This PDGF-induced FAK activation was also inhibited in Src/Yes/Fyn 
triple-knockout (SYF-/-) MEFs (Fig. 4-15). These results suggest that Src activity mediates the 
FAK activation in response to PDGF. I then asked whether FAK also regulates Src activation in 
response to PDGF. Src biosensor based on ECFP and YPet was previously developed
14
. In this 
study, I targeted this Src biosensor into DRM regions (Lyn-Src biosensor) to study the molecular 
interrelation between Src and FAK within these microdomains. As shown in Fig. 4-16A, the 
PDGF-induced FRET response of Lyn-Src biosensor was only partially reversed by PF228. 
Furthermore, PF228 did not prevent the PDGF-induced response of Lyn-Src biosensor (Fig. 4-
16B), suggesting that FAK activity is not required for the PDGF-induced Src activation. The 
portion of the Src activity which was sensitive to the FAK inhibitor may be attributed to the 
adhesion-dependent Src activation, mediated by FAK via its Tyr397 phosphorylation
20
.  
I further examined whether PI3K activity is crucial for the FAK/Src activation in 
response to PDGF. As an indicator of PI3K activity, I used a GFP-tagged Akt PH domain
18
, 
which can bind to PIP3 (a product of PI3K activity) and then translocate to the plasma membrane 
upon PI3K activation
24, 25
 (Fig. 4-17A). A specific PI3K inhibitor LY294002 (LY), which clearly 
inhibited the PDGF-induced PI3K activation (Fig. 4-17B), did not have any effect on the 
activation of either FAK or Src (Fig. 4-18), suggesting PI3K is not essential for the FAK/Src 
activation in response to PDGF. 
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The FAK activity is essential for the Src activation during cell adhesion  
I further explored the molecular relationship between FAK and Src at lipid rafts during 
cell adhesion process. The adhesion-induced FAK activation was not inhibited by PP1, but was 
abolished in SYF-/- cells (Fig. 4-19). The reconstitution of SYF-/- cells with either wild-type Src 
or kinase-dead Src restored the adhesion-mediated FAK activation (Fig. 4-19). These results 
indicate that the Src activity is not required for the FAK activation during adhesion process. 
Instead, other scaffolding domains of Src, e.g. SH2 and SH3 domains, may be important in this 
case.  
I next asked whether the FAK activity is required for the adhesion-induced Src activation. 
As shown in Fig. 4-20, the inhibition of FAK activity by PF228 completely blocked the 
adhesion-induced Src activation. This adhesion-induced Src activation is also abolished in FAK-
/- fibroblasts, which can be restored only by wild-type FAK, but not kinase-dead FAK (Fig. 4-
20). Therefore, in contrast to the PDGF-induced signaling pathway, the adhesion-mediated FAK 
activation is required for Src activation. Again, LY did not show any significant inhibitory effect 
on the adhesion-induced FAK/Src activations (Fig. 4-21), suggesting that PI3K activity is not 
required. 
 
 
Discussion 
 
FAK serves as a crucial integrator for various signaling networks in cell migration, 
mechanotransduction, and cancer development
26, 27
. These FAK functions are dependent on its 
subcellular locations due to different sets and concentrations of molecular intermediates at 
subcellular regions. For example, FAK promotes the dynamics of focal adhesions
28
, but inhibits 
that of invadopodia
29
. Therefore, FAK functions and the related molecular hierarchy should be 
investigated at the subcellular context. Recent evidence suggests that lipid rafts microdomains 
can guide the subcellular localization and activation of signaling molecules
21, 22, 30
. Indeed, while 
PDGF only induced a weak protein phosphorylation outside of lipid rafts, a significant increase 
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in protein phosphorylation can be observed within lipid rafts microdomains
31
. However, it 
remains unclear how FAK activation is regulated at membrane microdomains. 
In this study, a new FRET-based FAK biosensor was developed which is capable of 
monitoring the crucial molecular events in FAK activation: the autophosphorylation of Tyr397 
and its subsequent binding to the Src SH2 domain. An improved FRET pair, ECFP and YPet, 
was employed to enhance the sensitivity of the FAK biosensor. This new FAK biosensor has 
several advantages to study the signaling hierarchy at membrane microdomains in live cells. First, 
the substrate peptide encompassing Tyr397 of the FAK biosensor can be specifically 
phosphorylated by FAK, but not by Src, a well-regarded accompanying partner of FAK
20
 (Fig. 4-
2B and 4-4). Hence, this new FAK biosensor enabled the crucial differentiation between the 
FAK and Src actions. In addition, our new FAK biosensor mimics the molecular events of FAK 
activation to detect its activity, but does not contain the FAK kinase domain, which may cause 
side effects on the downstream signaling cascades. In fact, I have shown that the PDGF-induced 
ERK phosphorylation, a downstream signaling event of FAK activation, was not affected by the 
over-expression of the FAK biosensor at various concentrations (Fig. 4-22), suggesting that the 
FAK biosensor can allow the visualization of FAK activity in live cells without perturbing the 
endogenous cell signaling. Finally, FRET-based FAK biosensors with Lyn- and KRas-tags are 
ideal to visualize the local FAK activity at dynamic membrane microdomains in live cells with 
high accuracy. In fact, traditional biochemical methods to isolate proteins from DRM regions 
may alter protein solubility during detergent treatment
6
.  
I observed stronger FRET responses of lipid rafts-targeting FAK biosensor than that at 
non-raft regions, upon both cell adhesion and PDGF stimulations (Fig. 4-7 and 4-12). Indeed, 
lipid rafts microdomains may provide docking platforms to concentrate FAK and facilitate its 
activation. This notion is in line with previous observations connecting FAK and membrane 
microdomains: FAK can translocate to membrane rafts upon cell adhesion
32
; The clustering of an 
engineered ectodomain covalently fused to a membrane-tethered FAK by antibody-coated beads 
can induce FAK phosphorylation
33
; The elimination of the raft-protein caveolin blocked the FAK 
phosphorylation upon integrin activation
34
; The depletion of cholesterol and hence the disruption 
of membrane microdomains by methyl-β cyclodextrin (MβCD) also down-regulated FAK 
functions
21
; and FAK regulates the localization of membrane rafts to the leading edge of a 
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migrating cell to stabilize microtubules
22
. Furthermore, both the caveolin-containing membrane 
microdoamins and the focal adhesions have been shown to be highly ordered
35
, suggesting a link 
between raft structures and focal adhesions. I have previously shown in Chapter 3, with Src 
biosensors targeted at different membrane microdomains, that Src activation is faster and 
stronger at non-raft regions than at lipid rafts
7
. Previous immunostaining results also indicate that 
the majority of Src is not localized at focal adhesion sites as FAK does
36
. It is hence possible that 
only a minor fraction of Src co-localizes with FAK at membrane microdomains, which results in 
the observation of a moderate Src but major FAK activation at these microdomains
7
. Therefore, 
FAK and Src can be differentially localized and regulated to result in their distinct functions. 
Consistently, while FAK and Src cooperate closely at focal adhesions
20
, they have opposite 
effects on the development of invadopodia, which is promoted by Src, but inhibited by FAK
29
.   
These results also demonstrate the differential molecular hierarchy involving FAK and 
Src at membrane microdomains in response to different stimulations. During adhesion process, 
Src activation was dependent on the enzymatic activity of FAK (Fig. 4-20), suggesting that the 
FAK autophosphorylation on Tyr397, caused by its elevated kinase activity upon adhesion, may 
recruit the SH2 domain of Src to result in Src activation. In contrast, the FAK activation upon 
adhesion can occur in the absence of Src enzymatic activity (Fig. 4-19), consistent with previous 
findings that kinase-dead Src is capable of promoting the elevation of FAK activity and rescuing 
the phosphorylation at Tyr 397 in SYF-/- cells
36
. Although Src kinase activity was not necessary, 
Src molecule was still important for the FAK activation during the adhesion process, because a 
complete knockout of Src family members (SYF-/-) impaired the adhesion-mediated FAK 
activation (Fig. 4-20)
37
. It is possible that the scaffolding domains of Src, e.g. SH2 or SH3 
domain, may regulate the FAK functions during adhesion process, either by directly causing the 
FAK conformational change and the exposure of its kinase domain or by recruiting other 
signaling molecules to modulate the FAK activity.  
On the other hand, Src activity was found to be required for the FAK activation, whereas 
the FAK activity is not essential for the Src activation upon PDGF stimulation (Fig. 4-14 and 4-
16). Src can be activated by direct interaction between its SH2 domain and the phosphorylated 
PDGF receptors
38
. The activated Src kinase may then contribute to the FAK activation in various 
means: first, Src scaffolding domains may recruit FAK and its enzymatic activity can directly 
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phosphorylate the active loop in FAK, causing the full activation of FAK; or Src may recruit 
other signaling molecules which can cause the open active conformation of FAK. It is interesting 
that FAK kinase activity has a partial effect on maintaining the PDGF-induced Src activity, 
while it was not required for the activation of Src (Fig. 4-16A). It is possible that the interaction 
between the autophosphorylated FAK Tyr397 and Src SH2 domain may be important to 
maintain the active conformation of Src.  
In summary, by monitoring the crucial molecular events in the FAK activation, I have 
developed a novel FRET-based FAK biosensor which allows the detection of FAK activity with 
high spatiotemporal resolution in live cells. The targeting of the FAK biosensor at membrane 
microdomains via acylation and prenylation can further provide powerful tools to monitor the 
dynamic molecular activities at subcellular compartments. These results suggest that FAK can be 
activated at membrane microdomains with distinct molecular mechanisms in response to 
different physiological stimulations (Fig. 4-23). Therefore, by this distinct signaling hierarchy, 
cells may be able to tune the different mode of responses upon various physiological stimulations. 
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Figures 
 
 
Figure 4-1. The design of the FRET-based FAK biosensor. 
(A) The design of FAK biosensor. The FAK biosensor is composed of ECFP, SH2 domain 
derived from c-Src, a flexible linker, substrate peptide, and YPet. The substrate peptide is 
derived from FAK containing Tyr397 (indicated as red Y). (B) The principle of the biosensor 
response. Active FAK can phosphorylate the substrate peptide in the FAK biosensor (indicated 
as Y), which subsequently binds to the intramolecular SH2 domain to cause a FRET decrease.  
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Figure 4-2. In vitro characterization of FRET-based FAK biosensor. 
(A) Emission spectra of the purified FAK biosensor before (black) and after (red) the 
phosphorylation by active FAK for 2 hr. (B) The time course of the ECFP/YPet emission ratio of 
FAK biosensor (1 µM ) before and after the incubation with FAK (black circles), FAK in the 
presence of 1 µM PF228 (white diamonds), or Src (white circles). The time course of FRET 
ratios of FAK YF mutant biosensor (1 µM) was also shown (white triangles). The ECFP/YPet 
ratios were normalized against the averaged values before enzyme incubation. (C) The tyrosine 
phosphorylation level of the FAK biosensor before and after the incubation with FAK. The 
tyrosine phosphorylation level and total amount of the biosensor, immunoprecipitated from MEF 
cells, were detected by an anti-phosphotyrosine and anti-GFP antibody, respectively.  
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Figure 4-3. The specificity of the FAK biosensor in mammalian cells.  
The ECFP/YPet emission ratios (mean ± SEM) of the FAK biosensor in MEF cells in suspension 
(n=30) or adhered on FN (n=10) (left), and in FAK -/- cells in suspension (n=23) or adhered on 
FN (n=28) (right). *p=0.001 from student two-tailed t-test.  
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Figure 4-4 . The specificity of the FAK biosensor in mammalian cells.  
(A) ECFP/YPet emission ratios of the FAK biosensor (white bars) in FAK-/- MEF cells co-
expressing various constructs as indicated: FAK 1-375, the constitutively active FAK with the 
1-375 amino acids truncated from the full length FAK (n=18); FAK WT, wild type FAK (n=13); 
FAK NT, the negative mutant of FAK containing the N-terminal 1-400 amino acids (n=17); FAK 
KD, the kinase-dead FAK (n=15); Vector, empty vector pcDNA3 (n=12); Src WT, wild type Src) 
(n=24), and the ECFP/YPet emission ratios of the FAK mutant biosensor (black bars), YF 
(substrate tyrosine mutated, n=11) and RV (SH2 domain disrupted, n=21), in FAK-/- MEF cells 
co-expressing FAK 1-375. All values are shown as mean ± SEM and * represents the 
significant difference from other groups based on the multiple comparison test in Matlab. (B) 
The tyrosine phosphorylation and expression levels of the FAK biosensor or mutant biosensors 
(YF and RV) in the groups as described in (A). The tyrosine phosphorylation level and total 
amount of the biosensor, immunoprecipitated by an anti-GFP antibody from MEF cells, were 
detected by an anti-phosphotyrosine (pY20) and anti-GFP antibody, respectively.  
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Figure 4-5. The FAK biosensors targeted to the different compartments at the plasma 
membrane. 
(A) The design of membrane compartment-targeting FAK biosensors. The N-terminal Lyn tag 
can mediate the acylation of the biosensor to target it into DRM microdomains. The C-terminal 
KRas tag contains prenylation site and basic residues to target the biosensor to non-DRM 
regions at plasma membrane. (B) Sucrose gradient fractions of MEF cells expressing Lyn- or 
KRas-FAK biosensor. The fractions of each biosensor were analyzed by western blot with an 
anti-GFP antibody, and DRM regions were marked by an antibody for caveolin-1.  
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Figure 4-6. The representative ECFP emission images of the FAK biosensors with 
different targeting signals  
(A) Lyn and KRas (CS)-FAK biosensors, which has a mutation on the cysteine of Lyn- and 
KRas-tags to serine, and (B) Lyn-, KRas- and Cyto-FAK biosensors The site-specific mutations 
were generated using the QuickChange method (Stratagene). (Scale bar=10µm)  
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Figure 4-7. FAK activity is higher at lipid rafts upon adhesion. 
(A) The representative ECFP/YPet ratio images of Lyn-FAK and KRas-FAK biosensors 
expressed in MEF cells. The color bar on the left represents the ECFP/YPet ratio values. (Scale 
bar, 10 µm) (B) The ECFP/YPet emission ratio values (mean±SEM) of Lyn-FAK and KRas-FAK 
biosensors expressed in the adherent (on FN, white bars, n=14 for Lyn and n=9 for KRas) and 
suspended MEF cells (black bars, n=20 for Lyn and n-14 for KRas). *p=0.036 from student two-
tailed t-test. (C) The representative time course of the ECFP/YPet emission ratios of Lyn-FAK 
(black circles, n=5) and KRas-FAK (open circles, n=4) biosensors in response to 1 µM of PF228. 
(D) The representative time course of the ECFP/YPet emission ratios of Lyn-FAK (black circles, 
n=5) and KRas-FAK (open circles, n=3) biosensors in response to 5 mM of methyl-β-
cyclodextrin (MβCD).  
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Figure 4-8. Src activity upon cell adhesion is higher in non-raft regions.  
The ECFP/YPet emission ratio of Lyn- and KRas-Src biosensors in MEFs adhered on 
fibronectin (n=10). *p=0.008 from student two-tailed t-test.  
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Figure 4-9. In vitro kinase assays of the Lyn-FAK and KRas-FAK biosensors.  
The time courses of the normalized ECFP (478 nm)/YPet (526 nm) emission ratio of the purified 
Lyn-FAK (black circles) and KRas-FAK biosensor (white circles) were shown before and after 
the incubation with active FAK. The emission ratios were normalized against the averaged 
signals before the stimulation.  
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Figure 4- 10. The FAK activity is higher at focal adhesion sites.  
(A) A MEF cell expressing mcherry-paxillin. (B) The representative ECFP/YPet emission ratio of 
Lyn-FAK biosensor before and after the addition of PF228, a specific FAK inhibitor. The color 
bar represents the ranges of the ECFP/YPet emission ratio values. (C) The CFP/YPet emission 
ratios in (solid line) and outside (dotted line) of focal adhesion (FA) sites before and after PF228. 
(D) The ECFP/YPet ratio difference (mean ± SEM) between in and outside of FAs in cells 
treated before and after PF228 (n=8). * represents a significant difference (P<0.05).  
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Figure 4-11. The subcellular FAK activity reported by Lyn-FAK biosensor.  
The ECFP/YPet ratio difference (mean±SEM) between in and outside focal adhesions in MEF 
cells expressing Lyn- or KRas-FAK biosensor (n=7 or 8) as indicated. * p=0.027 from student 
two-tailed t-test.  
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Figure 4-12. The PDGF-induced FAK activation is higher at lipid rafts.  
(A) The representative ECFP/YPet ratio images of Lyn-FAK and KRas-FAK biosensors upon 10 
ng/ml of PDGF stimulation. (Scale bar, 10 µm) (B) The representative time courses of the 
normalized ECFP/YPet emission ratio of Lyn-FAK biosensor (black circles), KRas-FAK 
biosensor (white circles), and Lyn-FAK (YF) mutant biosensor (x symbol) before and after the 
PDGF stimulation. (C) The phosphorylation and expression levels of Lyn-FAK biosensor and the 
endogenous FAK Tyr397 from cells in suspension (Sus) or those adhered on fibronectin (FN) 
before and after PDGF stimulation. The tyrosine phosphorylation level and total amount of the 
biosensor, immunoprecipitated by anti-GFP antibody from MEF cells, were detected by an anti-
phosphotyrosine (pY20) and anti-GFP antibody, respectively. The phosphorylation and the 
expression of endogenous FAK were detected by an anti-phosphor-Tyr397 antibody and anti-
FAK antibody, respectively.  
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Figure 4-13. The PDGF-induced FAK activation at lipid rafts.  
(A and B) The representative ECFP/YPet emission ratio images and normalized time course of 
Lyn-FAK biosensor in response to PDGF stimulation, (A) with a subsequent treatment of 1 µM 
PF228 (n=5) or (B) 2.5 mM of methyl-β-cyclodextrin (MβCD) (n=4). (C) PDGF-induced tyrosine 
phosphorylation level of the PDGF receptor (PDGFR) with and without the pretreatment by 1 µM 
PF228. The PDGF receptors were immunoprecipitated from MEF cells. Overall tyrosine 
phosphorylation of PDGFR was detected by immunoblotting with an anti-phosphotyrosine 
antibody (pY20), and the total amount of PDGFR was measured by the anti-PDGFR antibody.  
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Figure 4-14. Src activity is essential for the FAK activation in response to PDGF 
stimulation.  
(A and B) The representative images and time courses of the normalized ECFP/YPet emission 
ratio of Lyn-FAK biosensor in response to 10 ng/ml PDGF in cells subjected to treatments with 
10 µM of PP1. (A) shows the results of post-PDGF treatment (n=5), and (B) shows pre-PDGF 
treatment (n=6). The time course emission ratios were normalized against the averaged signals 
before the stimulation. (Scale bar, 10 µm)  
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Figure 4-15. Src activity is essential for the FAK activation in response to PDGF 
stimulation.  
(A) The representative images and time courses of the normalized ECFP/YPet emission ratios 
of Lyn-FAK biosensor in SYF-/- MEF upon 10 ng/ml of PDGF stimulation. (Scale bar=10µm) (B) 
The averaged value (mean±SEM) of the normalized ECFP/YPet ratio of Lyn-FAK biosensor in 
SYF-/- MEF and MEF cells, after 15 min of the treatment of 10 ng/ml PDGF (n=4). *p=0.010 
from student t-test.  
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Figure 4-16. Src activity is essential for the FAK activation in response to PDGF 
stimulation.  
(A and B) The representative images and time courses of the normalized ECFP/YPet emission 
ratio of Lyn-Src biosensor in response to 10 ng/ml PDGF in cells subjected to treatments with 1 
µM of PF228. (A) shows the results of post-PDGF treatment (n=5), and (B) shows pre-PDGF 
treatment (n=6). The time course emission ratios were normalized against the averaged signals 
before the stimulation. (Scale bar, 10 µm) 
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Figure 4-17. Detection of PDGF-induced PI3K activation by a GFP-tagged Akt-PH probe.  
(A) A GFP-tagged Akt-PH domain construct, which can bind to PIP3 (a product of PI3K activity) 
and then translocate to the plasma membrane upon PI3K activation, was selected as an 
indicator of PI3K activity. To exclude 3D and geometric effects at different subcellular locations, 
mCherry protein was co-trasnfected with this PI3K indicator, and the GFP/mCherry ratio at 
regions around the cell periphery was measured to represent the activation level of PI3K. The 
representative pseudocolor images are those of the GFP-tagged Akt-PH probe (left panels), 
mCherry (middle panels), and GFP/mCherry emission ratio (right panels) in MEF cells before 
(upper panels) and after (lower panels) treatment with 10 ng/ml PDGF for 30 min. The color bar 
on the left of the ratio images indicates the GFP/mCherry ratio values. In the rest state, the 
GFP/mCherry ratio does not show significant variations at different locations of the cell (upper 
right panel). Upon PDGF stimulation, the GFP/mCherry ratio increased markedly at the 
peripheral regions (lower right panel, the areas highlighted by the arrows in the lower right 
panel). (Scale bar, 10 µm) (B) The representative time courses of the normalized intensities of 
the PI3K indicator in the peripheral regions in response to 10 ng/ml PDGF, with pre-PDGF 
treatment (right panel) or post-PDGF treatment (left panel) by 50 µM of LY294002 (LY) (n=6). 
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Figure 4-18. Effects of PI3K inhibitor on FAK and Src activation upon PDGF stimulation.  
The representative time courses of the normalized ECFP/YPet ratios of the Lyn-FAK (A) or Lyn-
Src (B) biosensors in response to 10 ng/ml PDGF, with the pre-PDGF treatment (right panel) or 
post-PDGF treatment (left panel) by 50 µM LY294002 (LY) (n=5-8).  
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Figure 4-19. FAK activation during cell-ECM adhesion is not dependent on Src kinase 
activity.  
The ECFP/YPet emission ratios (mean±SEM) of Lyn-FAK biosensor, in the adherent (on FN for 
1 hr, white bars) and suspended cells (black bars). The groups of cells include MEF, MEF+PP1 
(MEFs pre-treated with 10 µM PP1 for 1 hr), SYF (SYF-/- cells), SYF+SrcKD (SYF-/- cells 
reconstituted with the kinase-dead Src), or SYF+SrcWT (SYF-/- cells reconstituted with the wild-
type Src). *p=0.002 (MEF group), 0.0001 (MEF+PP1), 0.001 (SYF+SrcKD), and 0.006 
(SYF+SrcWT) from student two-tailed t-test.  
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Figure 4-20. FAK acts upstream to Src during the cell-ECM adhesion  
The ECFP/YPet emission ratios (mean±SEM) of Lyn-Src biosensor, in the adherent (on FN for 1 
hr, white bars) and suspended cells (black bars). The groups of cells include MEF, MEF+PF228 
(MEFs pre-treated with 1 µM PF228 for 1 hr), FAK-/- (FAK knockout MEFs), FAK-/-+FAK KD 
(FAK-/- cells reconstituted with the kinase-dead FAK), or FAK-/-+FAK WT (FAK-/- cells 
reconstituted with the wild-type FAK). *p=0.001 (MEF and FAK-/-+FAK WT groups) from student 
two-tailed t-test. (n=10-30).  
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Figure 4-21. Effects of PI3K inhibitor on FAK and Src activation upon cell adhesion.  
The ECFP/YPet emission ratios (mean±SEM) of Lyn-FAK (A) or Lyn-Src biosensors (B) (n=15). 
MEF cells expressing each biosensor were kept in suspension for 1 hr without (black bars) or 
with 50 µM of LY (white bars), and then re-plated on fibronectin-coated dish for 1 hr to measure 
the adhesion-induced FAK and Src activation.  
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Figure 4-22. FAK biosensor expression had no significant effect on the PDGF-induced 
ERK phosphorylation.  
The PDGF-induced phosphorylation level of endogenous ERK2 was measured in MEF cells 
transfected with different amounts of FAK biosensors or the control vector pcDNA3. Cells were 
collected before and after incubation with 10 ng/ml PDGF for various time periods as indicated.  
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Figure 4-23. Proposed signaling networks for the PDGF- and integrin-induced FAK 
signaling at membrane microdomains.  
The PDGF-induced FAK activation is dependent on Src. In contrast, the FAK activity and its 
subsequent Tyr397 phosphorylation are upstream to the Src activation in integrin-mediated 
adhesion processes.  
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CHAPTER 5 
DISTINCT MECHANISM OF FAK MECHANOACTIVATION BY 
DIFFERENT EXTRACELLULAR MATRIX PROTEINS 
 
Focal adhesion kinase (FAK) is localized at focal adhesions where outside mechanical 
signals can be translated inside cells
1
, and it has been proposed as an important regulator in 
mechanotransduction
2-4
. However, it is still unclear how FAK activity is regulated by mechanical 
environment, and in particular, how different extracellular matrix (ECM) molecules and specific 
integrin subtypes contribute to the mechanical tension-induced FAK activation. Here, I 
discovered, utilizing a genetically-encoded FAK biosensor based on fluorescence resonance 
energy transfer (FRET)
5
, FAK activation on fibronectin (FN) is more dependent on the surface 
rigidity than on collagen (CL), because mechanical tension-dependent unfolding of FN molecule 
is required for the activation of integrin 5β16 while CL can directly bind to and activate integrin 
2β1. In fact, when integrin 5β1 was directly activated by activating antibody, FAK can be 
activated, even in suspension, where no strong tension can be developed. These results suggest 
that outside mechanical signals can be differently translated inside cells through specific 
interactions between integrin subtypes and ECM molecules, which can result in different cellular 
processes.  
 
 
Introduction 
 
Living cells are continuously exposed to mechanical stimulations, e.g. shear stress, 
compression, and tensile stress. It becomes clear that the change in mechanical 
microenvironments plays crucial roles in normal cellular functions as well as progression of 
cardiovascular diseases and cancer
7-9
. For example, intracellular tension, developed by 
actomyosin-derived pulling force on the integrin-extracellular matrix (ECM) bond, can 
determine the physical architecture of the cell. The shape of the cell is crucial in cell survival and 
proliferation, while many cancer cells can modify their mechanical environments and proliferate 
without proper shape and intracellular tension
2
. Cells can sense and respond to the mechanical 
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microenvironment by converting it into biochemical signals inside the cells, i.e. 
mechanotransduction
5, 10, 11
. Recent studies have provided some evidence how mechanical 
tension can activate these molecules. For example, mechanical stretching of p130Cas promotes 
its phosphorylation by Src family kinases
12
. Unfolding purified talin rod domain by mechanical 
stretching allows the recruitment of vinculin, potentially reinforcing the connection between 
integrin and actin
13
. Myosin-II dependent endogenous tension has also been shown to directly 
unfold vinculin in living cells
14
.  
Focal adhesion kinase (FAK) has been proposed as an important regulator in 
mechanotransduction
2-4
. FAK can be localized at focal adhesions via its C-terminal FAT domain, 
which binds to paxillin or talin and hence connects it to integrins. When integrins bind to 
extracellular matrix molecules, the activated integrins can be clustered, also causing the 
clustering of FAK molecules. It is generally believed that this local high concentrations of FAK 
molecules at focal adhesions can result in its autophosphorylation at Tyr397 in trans
15
, which is 
required for the FAK activation. Integrins are heterodimeric transmembrane receptors containing 
 and β subunits, and so far 24 different subtypes of integrins have been identified in vertebrates 
with the combination of 18  and 8 β subunits16. These various integrin subtypes allow the 
diverse and specific recognition of different ECM molecules. More importantly, in response to 
the same mechanical stimulations, the interactions between different ECM molecules and 
specific integrin subtypes can lead to distinct signaling pathways and different cellular behaviors. 
For example, melanoma cells differently responded to substrate stiffness on the FN- or CL-
coated polyacrylamide gels, and a specific actin cross-linker filamin A is only required for cell 
stiffening on CL, but not for cell spreading on FN
17
. Shear stress stimulates the activation of 
integrins 5β1 and vβ3 in endothelial cells on FN, which then activates PKC and inhibits the 
activation of integrin 2β118. In contrast, in the cells seeded on CL, the activated integrin 2β1 
upon shear stress can stimulates PKA, suppressing the activation of integrins 5β1 and vβ318. 
Therefore, mechanical signals can be differently translated inside cells through the specific 
interactions between different ECM and integrin subtypes.  
To investigate how different ECM molecules and specific integrin subtypes contribute to 
the mechanical tension-induced FAK activation, polyacrylamide (PA) gels of different stiffness 
were prepared
5
, and the gel surface was coupled with different ECM molecules fibronectin (FN) 
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or collagen (CL). For visualizing the FAK activity in live cells, a specific FAK biosensor based 
on fluorescence resonance energy transfer was utilized
5
. This FAK biosensor is capable of 
specifically detecting crucial events in FAK activation, i.e. the autophosphorylation of Tyr397 
and its subsequent binding to the Src SH2 domain, by monitoring the changes in ECFP/YPet 
emission ratios of the biosensor. The results in this chapter showed that mechanical signals from 
microenvironment can be differentially translated inside cells through different interactions 
between specific ECM molecules and integrin subtypes. FAK activation on the FN-coated PA 
gels was more dependent on the tensional states, because the activation of integrin 5, which is 
necessary for the full activation of FAK, requires the mechanical tension-induced stretching of 
FN molecule. In contrast, CL-induced FAK activation through integrin 2 was less dependent on 
the tensional states. These surprising results demonstrate distinct mechanisms of FAK activation 
through different ECM molecules and their corresponding integrin subtypes. 
 
 
Materials and Methods 
 
DNA construction and plasmid 
FAK biosensor was recently developed based on FRET
5
. FAK mutants FRNK is a kind 
gift from Dr. Jun-Lin Guan (University of Michigan). 
 
Cell culture and reagents 
HT1080 and mouse embryonic fibroblast (MEF) cells were maintained in Dulbecco’s 
modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM L-
glutamine, 1 unit/ml penicillin, 100 µg/ml streptomycin, and 1 mM sodium pyruvate. Cell 
culture reagents were purchased from GIBCO BRL. Cells were cultured in a humidified 95% air, 
5% CO2 incubator at 37C. Lipofectamine 2000 (Invitrogen) was used for the transfection of 
DNA plasmids.  
Fibronectin from bovine plasma (FN) was purchased from Sigma, and type-I collagen 
from rat tail (CL) was purchased from BD Biosciences. Cytochalasin D (CytoD) and ML7 were 
obtained from Sigma.  
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Antibodies and peptides 
Integrin activating antibodies SNAKA51 (5 activating antibody), mAb11(5 control 
antibody), 12G10 (β1 activating antibody), 12G10 mAb are kind gifts from Dr. Martin 
Humphries (University of Manchester, UK). The β1control antibody, K20, was purchased from 
Santa Cruz Biotechnology. Anti-integrin 2β1 antibody was obtained from Millopore.  
GFOGER peptides and FNIII7-10 domains are kind gifts from Dr. Andres J. Garcia 
(Georgia Institute of Technology). 
 
Preparation of polyacrylamide gel and the coupling of the surface with ECM molecules 
Polyacrylamide gel is prepared as previously described
5
. Briefly, 40% w/v acrylamide 
and 2% w/v bis-acrylamide stock solutions (Bio-Rad) were used to prepare polyacrylamide gel 
solution. Different stiffness of the gel was achieved by varying the final concentrations of 
polyacrylamide solution (3%, 3%, 5.5%, and 7.5%) and bis-acrylamide crosslinker (0.04, 0.06, 
0.08, and 0.4%) for the corresponding stiffness of 0.2, 0.6, 2, and 40 kPa
19
.  To polymerize the 
solutions, 2.5 µl of 10% w/v ammonium persulfate (Bio-Rad) and 0.25 µl of N,N,N9,N9-
Tetramethylethylenediamine (TEMED; Bio-Rad) were added to yield a final volume of 500 ul 
polyarylamide solution. To crosslink extracellular matrix molecules onto the gel surface, sulfo-
SANPAH (sulfosuccinimidyl6(4'-azide-2'-nitrophenyl-amino) hexanoate, Pierce) was used, and 
200 µl of 0.1 mg/ml fibronectin solution (from bovine plasma, Sigma) or 0.1 mg/ml type-I 
collagen (from rat tail, Sigma) was incubated on top of the plyacrylamide gel at 37°C for 
overnight. 
 
Measurement of traction force  
The details of traction measurement have already been discussed elsewhere
3
. In brief, 
cells were cultured on polyacrylamide gels with red fluorescent beads (0.2μm in diameter) 
embedded in their top surface. Fluorescent image of the beads before and after trypsinization of 
the cells were captured. Displacement of the beads in the two images where computed using a 
MATLAB code. The traction field was then calculated from the displacement field using an 
established method discussed in 
20
. 
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Bead coating  
Ferromagnetic beads (Spherotech, 4.44 um in diameter) were covalently modified with 
GFOGER peptides or Poly-D-lysine (PDL) at 25, 75, or 150 µg protein per mg beads. To 
activate  the beads, the beads with carboxyl surface groups were incubated with 1-Ethyl-3-[3-
dimethylaminopropyl] carbodiimide hydrochloride (EDC, 10 mg/ml) and N-hydroxy-
succinimide (NHS, 10 mg/ml) in MES buffer (50 mM 2-(N-morpholino) ethanesulfonic acid, 
100 mM NaCl, pH 5.0) for 15 min at room temperature with constant mixing to activate the 
surface carboxyl groups. The beads then were centrifuged with 12000 rpm on an Eppendorf 
centrifuge for 15 min and the supernatant was removed. GFOGER peptides or PDL were added 
at 25, 75, or 150 µg per mg beads and incubated with beads in coupling buffer (HEPES 20 mM, 
100 mM NaCl, 5 mM CaCl2, pH 8.0) for 2 hrs with mixing at room temperature. The activated 
carboxyl groups covalently bind free amine groups on the protein. Quenching buffer (100 mM 
Tris, 20 mM NaCl, 5 mM CaCl2, pH 8.0) was added to stop the reaction and the free proteins 
were removed by centrifuging the beads and removing the supernatant. 
 
Image acquisition 
Cells were cultured in cover-glass-bottom dishes (Cell E&G) and maintained in CO2-
independent medium containing 0.5% FBS (Gibco BRL) at 37°C during imaging. Images were 
collected by a Zeiss Axiovert microscope and MetaFluor 6.2 software (Universal Imaging) with 
a 420DF20 excitation filter, a 450DRLP dichroic mirror, and two emission filters controlled by a 
filter changer (475DF40 for ECFP and 535DF25 for YPet). The excitation filter for ECFP at 
420±20 nm was selected to shift toward lower wavelength away from the peak excitation spectra 
of ECFP to reduce the cross-excitation of YPet and the effect of bleed-through on the FRET 
channel. The fluorescence intensity of non-transfected cells was quantified as the background 
signal and subtracted from the ECFP and YPet signals of transfected cells. The pixel-by-pixel 
ratio images of ECFP/YPet were calculated based on the background-subtracted fluorescence 
intensity images of ECFP and YPet by using the MetaFluor software. These ratio images were 
displayed in the intensity modified display (IMD) mode in which the color and brightness of 
each pixel is determined by the ECFP/YPet ratio and ECFP intensity, respectively. 
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Results 
 
FAK activity changes to the rigidity of the polyacrylamide gels coupled with fibronectin. 
To study the effect of substrate rigidity on FAK activity, a human fibrosarcoma HT1080 
cells were cultured on the polyacrylamide (PA) gels of different stiffness coated with fibronectin 
(FN), and FAK activity in live cells was visualized by a specific FAK biosensor based on 
fluorescence resonance energy transfer (FRET)
5
. This FAK biosensor is capable of specifically 
detecting crucial events in FAK activation, e.g. the autophosphorylation of Tyr397 and its 
subsequent binding to the Src SH2 domain, by monitoring the changes in ECFP/YPet emission 
ratios of the biosensor. The results show that the ECFP/YPet emission ratio of the FAK 
biosensor was increased as the substrate stiffness of FN-coated PA gels increases from 0.2 kPa to 
40 kPa (Fig. 5-1). This result suggests that the FAK activity increases on the more rigid surface 
coated with FN. 
I then measured the tractional stresses that HT1080 cells apply to the PA gels with 
different stiffness. The root-mean-square (RMS) traction was calculated from the displacement 
of the submicrometer fluorescent beads, embedded in the apical surface of PA gels, measured 
before and after the trypsinization of the cells
3
. Since cell projected area can strongly influence 
the magnitude of cell tractions and cell stiffness
21
,  we normalized traction by cell area to 
examine the effect of substrate stiffness. The results show that the traction per cell area in 
HT1080 cells on 40 kPa PA gel was significantly higher than on 0.6 kPa gel (Fig. 5-2). These 
results suggest that, as HT1080 cells with higher FAK activity can exert higher traction on more 
rigid surface through ECM molecule FN. 
 
FAK activity on FN is dependent on the intracellular tension induced by actomyosin-
derived contractility exerted on focal adhesions. 
Because FAK activity was higher with stronger tractional stresses, which can be 
developed by intracellular tension, I next investigated the effect of intracellular tension on FAK 
activity.  Intracellular tension can be developed by actomyosin-derived pulling force exerted on 
the integrins, and thus the inhibitors for actin polymerization and myosin light chain kinase 
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(MLCK), Cytochalasin D (CytoD) and ML7, respectively, were used to disrupt the intracellular 
tension. The FAK activation during cell adhesion on FN-coated gels was inhibited by incubation 
with ML7 (Fig. 5-3). In addition, the direct addition of both CytoD and ML7 markedly decreased 
the ECFP/YPet ratios of FAK biosensor (Fig. 5-4). These results suggest that FAK activity is 
indeed modulated by intracellular mechanical factors. 
I also observed the disassembly of focal adhesions (FAs) upon CytoD and ML7, as 
visualized by mcherry-tagged paxillin (Fig. 5-4, lower panels). These results suggest that the 
actomyosin-derived pulling force is required to maintain the stable focal adhesions and FAK 
activity. I further noticed that FA structure is required to maintain FAK activity. To 
simultaneously visualize the FA distributions and FAK activity, I generated the FAK biosensor 
with focal adhesion targeting (FAT) domain in its C-terminal (FAT-FAK biosensor). Focal 
adhesions started to be disassembled and no obvious FA was observed after 15 min of ML7 
treatment. FAK activity started to decrease later than FA disassembly, and FAK activity 
completely went down after 30 min of ML7 treatment (Fig. 5-5). These results suggest that the 
loss of actomyosin-derived pulling force and the subsequent FA disassembly, which can cause 
the decrease of intracellular tension, resulted in the decreased FAK activity. In fact, the 
mechanical tension-induced FAK activation was abolished by expressing FAK mutant FRNK, 
which contains the C-terminal FAT domain and blocks the correct localization of endogenous 
FAK at focal adhesions
22
. The result shows that, in control cells, the ECFP/YPet ratio of FAK 
biosensor was significantly increased on the rigid gel (40 kPa) than on the soft gel (0.6 kPa), but 
the FAK activation by rigid environment was not observed in the cells expressing FAK mutant 
FRNK (Fig. 5-6). Therefore, the proper localization of FAK molecules to interact with integrins 
is required for the FAK activation by mechanical environments. 
 
Collagen-induced FAK activation does not require the intracellular tension. 
I next investigated how FAK activity is modulated by surface rigidity coated with another 
ECM molecule, type-I collagen. The result shows, surprisingly, FAK activity was not changed 
on different surface stiffness (Fig. 5-7). High FAK activity was also observed on the soft PA gels, 
whereas the traction on soft 0.6 kPa gel was still significantly lower than on 40 kPa gel (Fig. 5-8). 
This FAK activation on the CL-coated soft 0.6 kPa gel during cell adhesion was not inhibited by 
10 µM of ML7 (Fig. 5-9), while FAK activation was inhibited by ML7 on the FN-coated gels 
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(Fig. 5-3B). These results suggest that FAK activation on the soft environment coupled with CL 
is not dependent on actomyosin-derived intracellular tension. Therefore, in sharp contrast to FN-
induced FAK activation, CL-induced FAK activation was no longer dependent on the substrate 
rigidity and intracellular tension.  
To further confirm the result that CL-induced FAK activation is independent on the 
intracellular tension, I tested whether CL can induce the FAK activation in suspension. As 
mentioned earlier, intracellular tension can be developed by the actomyosin-derived pulling force 
at the focal adhesions where cells adhere on and interact with outside environments through 
integrins at plasma membrane. Thus, it is expected that, without strong adhesion, i.e. in 
suspension, no strong intracellular tension can be developed. Surprisingly, FAK activation was 
still observed when CL was directly applied to HT1080 cells in suspension (Fig. 5-10). The 
ECFP/YPet ratio of FAK biosensor in the suspended cells was significantly increased by CL, and 
this increased FRET level was similar to the one in the cells adhered on the CL-coated surface 
(Fig. 5-10B). In contrast to CL, no FAK activation in the suspended HT1080 cells was observed 
by the addition of soluble FN (Fig. 5-10). Because FN-induced FAK activation was dependent 
on the intracellular tension, it is expected that the low tensional state, like in suspension, could 
not be enough to cause FN-induced FAK activation. 
I next tested whether the CL-induced FAK activation in suspension is dependent on 
actomyosin-derived intracellular tension. When the suspended HT1080 cells were incubated with 
10 µM of ML7 together with soluble CL, FAK can be still activated (Fig. 5-11), whereas FAK 
activation on the FN-coated surface was inhibited by ML7 (Fig. 5-3 and 5-4). These results 
suggest that the CL-induced FAK activation is not dependent on the intracellular tension, in the 
suspension states, where in fact the tension cannot be properly built up. The increased 
ECFP/YPet ratio of FAK biosensor by CL in suspension was specifically due to FAK activation, 
because the FAK inhibitor PF228 completely blocked this ratio change (Fig. 5-11). 
The CL-induced FAK activation in suspension was inhibited by the inhibitory antibody against 
integrin 2β1, suggesting the interaction between CL and integrin 2β1 is crucial (Fig. 5-12). In 
addition, the cells expressing FRNK did not induce the FAK activation by CL in suspension (Fig. 
5-12), indicating the FAT domain function is required for the FAK activation. These results 
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suggest that the ECM molecule CL binds to integrin 2β1 and FAK can be activated through the 
interaction of its C-terminal FAT domain with integrin 2β1-associated proteins.  
 
CL-induced FAK activation in suspension is through the clustered GFOGER peptides sites. 
CL-induced FAK activation was mediated by the activated integrin 2β1 (Fig. 5-12), 
thus I further tested whether FAK can be activated by GFOGER peptides, which are the binding 
motif of CL to integrin 2β1. The results show that, while the ECFP/YPet ratio of FAK 
biosensor increased by CL, the higher concentration of GFOGER peptides induced no significant 
FAK activation (Fig. 5-13). I hypothesized that, compared to CL, GFOGER peptides may be 
diffused in the solution and not enough to cause the clustering of integrins and FAK molecules, 
which is required for the autophosphorylation and activation of FAK. Thus, I prepared the beads 
coated with different concentrations of GFOGER peptides, and applied them to the cells on poly-
D-lysine (PDL)-coated surface. The ECFP/YPet ratio of FAK biosensor was increased near the 
area of GFOGER-coated beads attachment with a concentration-dependent manner (Fig. 5-14A 
and B). To test whether the bead binding itself caused the FAK activation, we used PDL-coated 
beads as control. No significant change in the ECFP/YPet ratio of FAK biosensor was observed 
by the attachment of PDL-coated beads (Fig. 5-14A and B), suggesting that the FAK activation 
induced by GFOGER peptides-coated beads is indeed due to the clustered binding motif to 
integrin 2β1. In addition, the increased ECFP/YPet ratio of FAK biosensor by the attachment of 
GFOGER peptides-coated beads was not decreased by the subsequent addition of ML7 (Fig. 5-
14C). Therefore, the CL-induced FAK activation, which was less dependent on the tensional 
state, is mediated by the direct interaction between integrin 2β1 and the clustered binding sites 
GFOGER of CL.    
 
FN-induced FAK activation is regulated by intracellular tension because the activation of 
integrin 5β1 is tension-dependent 
The results show that intracellular tension was essential for the FAK activation by FN, 
but not by CL. Thus, I further studied the mechanism of different FAK activation depending on 
the engaged ECM molecules. I hypothesized that the interactions of different ECM molecules 
with their corresponding integrin subtypes may contribute to these distinct mechanisms of FAK 
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activation. FN can bind to both integrins 5β1 and vβ3, but in HT1080 cells, 5β1 is the major 
corresponding integrin subtype (Fig. 5-15). It has been suggested that integrin 5β1 can exist as 
either relaxed or tensioned state when bound to FN, and FAK can be activated only by the 
tensioned state of integrin 5β1, which is supported by actomyosin-derived tension23. In the 
relaxed state of integrin 5β1, only β1 subunit binds to RGD peptides of FNIII10, but when 
integrin 5β1 switches its state to be tensioned, 5 subunit can be additionally bind to the 
synergy site in FNIII9 nearby RGD peptides
23
. In fact, in the tensioned state, FN molecule can be 
stretched to expose the synergy site for this additional binding to integrin 5 subunit6. Thus, in 
the lower tensional state, the FN synergy site may not be able to bind to integrin 5, resulting in 
no full activation of integrin 5β1 as well as FAK. Because FN molecule cannot expose the 
synergy site in the low tensional state, such as in suspension, it is possible that integrin 5 cannot 
be activated by FN, preventing FAK activation.  
Therefore, I tested whether FAK can be activated in suspension, if integrin 5β1 is 
directly activated by activating antibodies. Surprisingly, we can observe the FAK activation 
when the HT1080 cells in suspension was incubated with 5 activating antibody SNAKA51, and 
β1 binding motif RGD peptides (Fig. 5-16). This interesting result indicates that FAK can be 
activated, even in suspension, by directly activating integrin 5β1. This result also suggests that 
previously the addition of FN did not induce the FAK activation in suspension (Fig. 5-10), 
because the FN synergy site cannot be exposed in the suspended state and hence integrin 5β1 
cannot be fully activated to cause the FAK activation. The ECFP/YPet ratio of FAK biosensor by 
mAb11 (a control antibody for SNAKA51) together with RGD peptides, was significantly lower 
than the one with SNAKA51 (Fig. 5-16B), suggesting the specificity of the antibody. In addition, 
the incubation of ML7 did not affect the FAK activation in suspension by RGD and SNAKA51 
(Fig. 5-17). Therefore, these results suggest that FN-induced FAK activation is dependent on 
mechanical tension because the exposure of the FN synergy site and the activation of integrin 
5β1 are tension-dependent. The ligation of RGD peptides to integrin β1 subunit alone can 
slightly  increase the ECFP/YPet ratio of FAK biosensor (around 20%, Fig. 5-16B), but it seems 
the RGD ligation is not enough to fully activate integrin β1 to the level as shown by 12G10, 
integrin β1 activating antibody (around 70%, Fig. 5-18). In addition, the incubation with 
SNAKA51 alone did not cause any FAK activation (Fig. 5-16B). Therefore, FAK can be fully 
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activated when both integrin 5 and β1 subunits are activated by binding to the FN synergy site 
and RGD peptides, respectively. 
The incubation of SNAKA51 with the whole FN molecule did not induce the FAK 
activation (Fig. 5-19), because FN exists as a folded compact structure in solution
6
, not exposing 
integrin β1 binding RGD sites. FNIII7-10 domains, which include both RGD peptides and the 
synergy site, caused some increase of FAK activity (around 30%), suggesting the exposure of 
RGD sites in FNIII7-10 domains. However, the addition of SNAKA51 did not further increase 
the ECFP/YPet ratio of FAK biosensor to the level of the group RGD+SNAKA51 (around 50%), 
possibly due to the steric hindrance effect of FNIII7-10 domain which may block the access of 
SNAKA51 to integrin 5. Different concentrations of FN, FNIII7-10 domains, and RGD 
peptides were further tested, but they were not enough to fully activate FAK (Fig. 5-20). 
 
The distinct binding structures of integrin subtypes with different ECM molecules can 
contribute to different mechanisms of FAK activation 
In contrast to the tensioned 5β1-FN bond, integrin 2β1 is known to bind to GFOGER 
peptides of CL through 2 I-domain and no other additional binding site of CL was discovered24. 
I-domain of  subunit is the unique domain of integrin 2 which is not found in integrin 5. It 
has been proposed that the ligand-binding to  I-domain causes its conformational change, 
which then induces the subsequent binding of internal ligand Glu to integrin β subunit16. This 
can further cause the conformational change of integrin β subunit, eventually resulting in the full 
integrin activation and the related signaling cascades such as FAK
16
. Thus, CL can directly bind 
to and activate integrin 2β1 through GFOGER sites (Fig. 5-10, 5-12 and 5-14), possibly 
without further unfolding of CL molecule, and therefore, the CL-induced FAK activation can be 
less dependent on mechanical environment. In fact, the ECFP/YPet ratio of FAK biosensor by 
CL was comparable to the FRET level induced by β1 activating antibody 12G10 (around 70%, 
Fig. 5-18). The control antibody K20 did not cause any change in the ECFP/YPet ratio of FAK 
biosensor (Fig. 5-18), suggesting the specificity of the antibody 12G10. In addition, 12G10 mAb 
still caused the significant increase in the ECFP/YPet ratio of FAK biosensor (Fig. 5-21), 
suggesting that the FAK activation by 12G10 is not due to non-specific clustering of antibodies. 
Different concentrations of antibodies were also tested (Fig. 5-22). These results suggest that the 
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distinct binding structures of integrin subtypes with different ECM molecules can contribute to 
these different mechanisms of FAK activation: The FAK activation by integrin 5β1-FN 
interaction is dependent on the intracellular tension, whereas integrin 2β1-CL ligation can 
induce the FAK activation, independent on the mechanical factors.  
I observed FAK activation, in suspension, by directly activating integrin 5β1 and 2β1 
with activating antibodies (Fig. 5-16 and 5-18). I further tested whether FAK can be still 
activated, on the soft 0.6 kPa gel, when the surface is coupled with the activating antibodies. The 
result shows that FAK can be activated on the soft gel coated with 12G10 to the similar level on 
the CL-coated soft gel (Fig. 5-23). This result suggests that the activated integrin β1 can induce 
FAK activation on this soft environment, independent of mechanical factor surface rigidity. In 
addition, although the average ECFP/YPet ratio of FAK biosensor on the soft gel coated with 
SNAKA51 and RGD was not obviously increased compared to on the FN-coated soft gel, the 
histogram of cell populations shows a new group of cells with higher ECFP/YPet ratio (Fig. 5-23, 
arrow). It is possible that the orientation and distribution of SNAKA51 and RGD on the fixed 
surface might be not as efficient as in the solution, to induce the activation of integrin 5β1. The 
incubation with 10 µM of ML7 did not abolish this FAK activation on the soft gel coated with 
activating antibodies (Data not shown). These results suggest that FAK can be activated on the 
soft environment by the activated integrins, and also indicate that the mechanical factor surface 
rigidity influences the integrins activation to modulate FAK activity. Again, the expression of 
FRNK mutant abolished the FAK activation in suspension induced by directly activating integrin 
5β1 (Fig. 5-24), suggesting FAK can be activated by the proper interactions with integrins at 
focal adhesions. Therefore, the distinct binding structures of integrin subtypes with different 
ECM molecules can contribute to these different mechanisms of FAK activation: The FAK 
activation by integrin 5β1-FN interaction is dependent on the intracellular tension, whereas 
integrin 2β1-CL ligation can induce the FAK activation, independent on the mechanical factors 
(Fig. 5-25). 
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Discussion 
 
Cells can interact with various extracellular matrix (ECM) molecules through different 
integrin subtypes at focal adhesions, recruiting the signaling molecules, e.g. focal adhesion 
kinase (FAK), as well as connecting to actin cytoskeleton. As the bonds between integrins and 
ECM molecules become stronger, more actomyosin fibers can be bundled, exerting the stronger 
contractile force on these matured focal adhesions. And this stronger contractile force derived 
from actomyosin fibers can be a major source for the intracellular tension. This cellular traction 
force can regulate cellular processes as well as modify the surrounding microenvironments, e.g. 
unfolding fibronectin molecules
6
. FAK is one of the key molecules localized at focal adhesions
1
, 
where the actomyosin-derived pulling force is exerted on. In this chapter, I studied how FAK 
activity is regulated by mechanical factors, in particular, how different interactions of integrin 
subtypes and ECM molecules contribute to the mechanical tension-induced FAK activation. 
The results in this study showed that FAK activity increases on the rigid surface coupled 
with FN, where the stronger intracellular tension can be developed (Fig. 5-1 and 5-2). Because 
the stiff substrate provides more stable anchorage force that can resist the stronger actomyosin-
derived contractile force, contributing the higher intracellular tension, these results imply that 
FAK can be activated as the intracellular tension builds up. In fact, this FAK activity decreased 
back to the basal level when the actomyosin-derived pulling force was disrupted by CytoD or 
ML7 (Fig. 5-3 and 5-4). These results suggest that FAK activity on FN-coated surface can be 
modulated by internal mechanical factors as well as outside mechanical environments. In 
contrast, FAK activation in HT1080 cells was not dependent on substrate rigidity when the 
surface is coated with another ECM molecule CL, although tractional stresses were still 
increased on the stiff substrate, like on FN-coated surfaces (Fig. 5-7 and 5-8). In addition, CL 
induced the FAK activation even in suspension, where no significant intracellular tension can be 
developed (Fig. 5-10). These results suggest distinct mechanisms of FAK activation by 
mechanical environments depending on the engaged ECM molecules on the surface: intracellular 
tension is essential for the FAK activation on FN, but not on CL.  
These different mechanisms of FAK activations on FN and CL were due to the distinct 
binding structures of integrin subtypes with different ECM molecules (Fig. 5-25). FN-interacting 
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integrin 5β1 can be fully activated when both 5 and β1 subunits bind to the FN synergy site 
and RGD peptides, respectively
23
. However, only in the tensional states, FN can be stretched to 
expose the synergy site which binds the integrin 5 subunit6. Therefore, FAK activation by FN-
integrin 5β1 interaction can be dependent on the intracellular tension. In contrast, CL-
interacting integrin 2β1 can directly bind to GFOGER peptides of CL through the 2 I-
domain
24
, causing the conformation changes of both 2 and β1 subunits and hence the activation 
of integrin 2β1 and FAK16. Therefore, FAK activation through CL-integrin 2β1 interaction 
can be less dependent on the tensional states. 
These results suggest that mechanical signals, e.g. surface rigidity, can be differently 
translated inside the cells because the activation mechanisms of different integrin subtypes were 
different: integrin 5β1 can be activated in the tensional states, whereas the activation of integrin 
2β1 was less dependent on the tensional states. In fact, when these integrins were directly 
activated by antibodies, both integrin 5β1 and 2β1 can mediate the downstream signaling, 
FAK activation (Fig. 5-16 and 5-18), indicating that the mechanical signals are translated at the 
level of integrins. The results in this chapter also suggest that, through FN-integrin 5β1 
interactions, the mechanical signals were more precisely translated inside the cells to activate 
FAK. It is possible that tension-independent FAK activation by CL-integrin 2β1 interaction 
may bypass the limitations in some mechanical environments e.g. cancer, allowing various FAK 
functions such as cell migration, proliferation and survival. Therefore, this study with a sensitive 
FRET-based FAK biosensor provides new insights on the function of ECM molecules and 
specific integrin subtypes in FAK activation by mechanical environments. 
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Figures 
 
 
 
 
 
 
Figure 5-1. FAK activity increases on the rigid surface coated with fibronectin (FN).  
The representative images (A) and the average ECFP/YPet ratio values of FAK biosensor 
(n=19-31) (B) in HT1080 cells cultured on the FN-coated polyacrylamide (PA) gels of different 
stiffness as indicated. The color bars on the left represent the ECFP/YPet ratio values. Graphs 
show mean ± SEM. * represents a significant difference (P<0.05). Scale bar=10 µm.  
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Figure 5-2. The traction force per area in HT1080 cells on the FN-coated PA gels of 0.6 
kPa and 40 kPa (n=3). Graphs show mean ± SEM. * represents a significant difference 
(P<0.05). 
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Figure 5-3. FAK activation on FN is dependent on actomyosin-derived intracellular 
tension.   
(A) The average ECFP/YPet ratio of FAK biosensor in HT1080 cells adhered on FN-coated 
glass surface after the incubation with different concentrations of ML7 for 1 hr (n=28-37). (B) 
The average ECFP/YPet ratio of FAK biosensor in HT1080 cells after 2 hrs of adhesion on the 
FN-coated PA gels of 0.6 kPa and 40 kPa stiffness with or without 10 µM of ML7 (n=25-34). 
Graphs show mean ± SEM. * represents a significant difference (P<0.05).  
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Figure 5-4. FAK activation on FN is dependent on actomyosin-derived intracellular 
tension.   
The representative ECFP/YPet ratio images of FAK biosensor (upper panels) and mcherry-
tagged paxillin (lower panels) upon the treatment of 10 µM of ML7 (A) or 1 µM of CytoD (B) for 
the time as indicated (n=20).  
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Figure 5-5. The disruption of actomyosin-derived pulling force causes the disassembly of 
focal adhesions as well as the decreased FAK activity. 
The representative ECFP/YPet ratio images of FAT-FAK biosensor upon the treatment of 10 µM 
of ML7 for the time as indicated. Scale bar=10 µm.  
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Figure 5-6. FAK activation on the rigid surface coated with FN is dependent on the 
function of C-terminal FAT domain. 
The average ECFP/YPet ratio values of FAK biosensor in HT1080 cells expressing FAK mutant 
FRNK, on the PA gels of 0.6 kPa (black bars) and 40 kPa (white bars) (n=18-21). Graphs show 
mean ±SEM. * represents a significant difference (P<0.05).  
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Figure 5-7. FAK activity is not dependent on surface rigidity when coupled with type-I 
collagen (CL).  
The representative images (A) and the average ECFP/YPet ratio values of FAK biosensor 
(n=18-19) (B) in HT1080 cells cultured on the CL-coated PA gels of different stiffness as 
indicated.  
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Figure 5-8. The traction force per area in HT1080 cells on the CL-coated PA gels of 0.6 
kPa and 40 kPa (n=3). 
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Figure 5-9. FAK activity on CL-coated soft gel is not dependent on actomyosin-derived 
intracellular tension.  
(A) The representative ECFP/YPet ratio images in H1080 cells adhered on CL-coated 0.6 kPa 
gel with or without 10 µM of ML7. (B) The average ECFP/YPet ratio of FAK biosensor in 
HT1080 cells after 2 hrs of adhesion on the CL-coated PA gels of 0.6 kPa and 40 kPa stiffness 
with or without 10 µM of ML7 (n=28-47). Graph shows mean ±SEM. * represents a significant 
difference (P<0.05).  
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Figure 5-10. FAK is activated, in suspension, by type-I collagen.  
The representative images (A) and the average ECFP/YPet ratio values of FAK biosensor (B) in 
HT1080 cells suspended for 1 hr and subsequently treated with 40 µg/ml of CL or FN for 
another 1 hr. The image in the low right panel (CL matrix) shows the image of FAK biosensor in 
the cell adhered on the CL-coated surface (n=45-50). The ECFP/YPet ratio of each group was 
normalized with the value of suspension group as 1. Graph shows mean ±SEM. * represents a 
significant difference (P<0.05). Scale bar=10 µm.  
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Figure 5-11. CL-induced FAK activation in suspension is not dependent on actomyosin-
derived intracellular tension. 
The average ECFP/YPet ratios of FAK biosensor in the suspended HT1080 cells with 1% 
DMSO, and the cells treated with 40 µg/ml of CL together with 1% DMSO,10 µM of ML7 or 1 µM 
of PF228 (n=14-19). The ECFP/YPet ratio of each group was normalized with the value of 
suspension group as 1. Graph shows mean ±SEM. * represents a significant difference 
(P<0.05).  
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Figure 5-12. CL-induced FAK activation in suspension is mediated by the interaction 
between its FAT domain and integrin 2β1. 
The average ECFP/YPet ratios of FAK biosensor in the suspended HT1080 cells before (black 
bars) and after the incubation of 40 µg/ml of CL (white bars). HT1080 cells were co-transfected 
with FAK mutant FRNK or treated with 10 µg/ml of the inhibitory antibody for integrin 2β1 
(n=20-37). The ECFP/YPet ratio of each group was normalized with the value of suspension 
group as 1. Graph shows mean ±SEM. * represents a significant difference (P<0.05).  
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Figure 5-13. FAK is activated by CL, but not GFOGER peptides, in suspension. 
The representative images and the average ECFP/YPet ratio values of FAK biosensor in the 
suspended HT1080 cells by the incubation with different concentrations of CL (n=24-50) (A) or 
GFOGER peptides (n=24-34) (B). The ECFP/YPet ratio of each group was normalized with the 
value of suspension group as 1. Graphs show mean ±SEM. Scale bar=10 µm. 
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Figure 5-14. CL-induced FAK activation in suspension is through the clustered GFOGER 
peptides sites. 
(A) The average ECFP/YPet ratio values of FAK biosensor near the area of the attachment of 
beads coated with 75 µg/mg bead of Poly-D-Lysine (PDL) or 25, 75, 150 µg/mg bead of 
GFOGER peptides, in cells adhered on PDL-coated surface (n=12-30). (B) The representative 
ECFP/YPet ratio images of FAK biosensor by the attachment of bead coated with 75 µg/mg 
bead of PDL or GFOGER peptides. The lower panels are the enlarged images of the region 
near the bead attachment. (C) The representative ECFP/YPet ratio images of FAK biosensor 
with the attachment of GFOGER bead (150 µg/mg bead) before and after the treatment of 10 
µM ML7 (left) and the average ECFP/YPet ratio values of FAK biosensor before and after ML7 
treatment (n=14-26). Graphs show mean ±SEM. * represents a significant difference (P<0.05). 
Scale bar=10 µm. 
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Figure 5-15. FN-induced FAK activation in HT1080 cells are mediated by integrin 5β1.  
(A) The representative DICIII image of HT1080 cells applied on FN-coated polyacrylamide gels 
of different rigidity without or with the incubation of inhibitory antibody for integrin 5β1 or vβ3. 
(B and C) The average ECFP/YPet ratio of FAK biosensor in HT1080 cells on different stiffness 
gels treated with inhibitory antibody for integrin 5β1 (n=3 and 7) (B) or vβ3 (n=7 and 12) (C). 
Graphs show mean ±SEM. * represents a significant difference (P<0.05). Scale bar=10 µm. 
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Figure 5-16. FAK can be activated, in suspension, by the activation of integrin 5β1.  
The representative images (A) and the average ECFP/YPet ratio values of FAK biosensor (B) in 
the suspended HT1080 cells after the incubation of SNAKA51 (5 activating antibody, 10 µg/ml), 
RGD peptides (40 µg/ml), RGD with SNAKA51, or RGD with mAb11 (control antibody for 
SNAKA51, 10 µg/ml) (n=23-38). The ECFP/YPet ratio of each group was normalized with the 
value of suspension group as 1. Graphs show mean ±SEM. * represents a significant difference 
(P<0.05). Scale bar=10 µm. 
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Figure 5-17. FAK activation by integrin 5β1 in suspension is not dependent on 
actomyosin-derived intracellular tension. 
The average ECFP/YPet ratio values of FAK biosensor in the suspended HT1080 cells after the 
incubation of RGD (40 µg/ml) and SNAKA51 (10 µg/ml), without or with 10 µM ML7 (N=21-26). 
The ECFP/YPet ratio of each group was normalized with the value of suspension group as 1. 
Graph shows mean ±SEM. * represents a significant difference (P<0.05). 
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Figure 5-18. CL can cause FAK activation in suspension through the activation of 
integrin β1.  
The average ECFP/YPet ratios of FAK biosensor in the suspended HT1080 cells treated with 
CL (40 µg/ml), 12G10 (β1 activating antibody, 10 µg/ml), or K20 (control antibody for 12G10, 10 
µg/ml) (n=14-27). The ECFP/YPet ratio of each group was normalized with the value of 
suspension group as 1.Graphs show mean ±SEM. * represents a significant difference (P<0.05).  
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Figure 5-19. The full activation of integrin 5β1 can be activated by SNAKA51 together 
with RGD, but not with FN or FNIII7-10 domain. 
The average ECFP/YPet ratio values of FAK biosensor in the suspended HT1080 cells after the 
incubation of RGD peptides (40 µg/ml), RGD with SNAKA51 (10 µg/ml), RGD with mAb11 (10 
µg/ml), FN (40 µg/ml), FN with SNAKA51, FNIII7-10 domain (40 µg/ml), or FNIII with SNAKA51 
(n=20-31). The ECFP/YPet ratio of each group was normalized with the value of suspension 
group as 1. Graphs show mean ±SEM. * represents a significant difference (P<0.05). 
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Figure 5-20. FAK activation level by different concentrations of FN, FNIII7-10, or RGD 
peptides. 
The average ECFP/YPet ratio values of FAK biosensor in the suspended HT1080 cells after the 
incubation of different concentrations of FN (A), FNIII7-10 domain (B), or RGD peptides (C) 
(n=18-31). The ECFP/YPet ratio of each group was normalized with the value of suspension 
group as 1. Graphs show mean ±SEM.  
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Figure 5-21. The FAK activation by 12G10 is truly due to the activation of integrin β1, but 
not clustering effect of activating antibody. 
The average ECFP/YPet ratio values of FAK biosensor in the suspended HT1080 cells after the 
incubation with 10 µg/ml of 12G10 or 12G10 mAb  (n=20-26). The ECFP/YPet ratio of each 
group was normalized with the value of suspension group as 1. Graphs show mean ±SEM. * 
represents a significant difference (P<0.05).  
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Figure 5-22. FAK activation level by different concentrations of integrin activating or 
control antibodies. 
The average ECFP/YPet ratio values of FAK biosensor in the suspended HT1080 cells after the 
incubation of different concentrations of antibodies (n=14-27). The ECFP/YPet ratio of each 
group was normalized with the value of suspension group as 1.  
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Figure 5-23. FAK can be activated on the soft gels coated with integrin activating 
antibodies. 
The histogram of cell populations with different ECFP/YPet ratio of FAK biosensor in HT1080 
cells adhered on 0.6 kPa gels coated with (A) 12G10 (100 µg/ml), (B) SNAKA51 (150 µg/ml) 
and RGD (150 µg/ml), (C) CL (100 µg/ml) or  (D) FN (100 µg/ml). The arrow in (b) shows the 
cell populations with high ECFP/YPet ratios.  
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Figure 5-24. FAK activation by integrin 5β1 in suspension is dependent on FAT domain 
function. 
The average ECFP/YPet ratios of FAK biosensor in the suspended HT1080 cells expressing 
FAK mutant FRNK, without (black bars) or with the incubation of 40 µg/ml RGD and 10 µg/ml 
SNAKA51 (n=19-55). The ECFP/YPet ratio of each group was normalized with the value of 
suspension group as 1. Graphs show mean ±SEM. * represents a significant difference 
(P<0.05). 
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Figure 5-25. Proposed FAK activation mechanism by different integrin subtypes, 5β1 
and 2β1. 
Integrin 5β1 can be fully activated when both FN synergy site and RGD peptides bind 5 and 
β1 subunit, respectively. Because the FN synergy site is exposed only in the tensional state, the 
activation of integrin 5β1 is dependent on the mechanical environment. In contrast, integrin 
2β1 can directly bind to GFOGER peptides of CL, causing its activation. FAK can be activated 
when each integrin is activated.  
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CHAPTER 6 
CONCLUSIONS 
 
 
Summary and potential outcomes of the thesis 
 
Cells continuously respond to chemical and mechanical environmental cues such as 
growth factors, extracellular matrix (ECM) molecules, neighboring cells, and surface rigidity. 
They sense these extracellular signals through receptors at plasma membrane, e.g. growth factor 
receptors, integrins, cadherins, and ion channels. These signals can be transferred inside the cells, 
i.e. signal transduction, by modulating the activity of signaling molecules and/or altering gene 
expression of specific proteins. Src and focal adhesion kinase (FAK) are crucial signaling 
molecules involved in many cellular processes such as cell adhesion, spreading, migration, 
proliferation and survival
1, 2
. When Src/FAK signal transduction is not properly working, these 
cellular responses cannot be regulated and diseases such as cancer can be developed
3
. Therefore, 
it is important to understand how chemical and mechanical environmental signals are translated 
inside the cells through Src/FAK signal transduction. 
To visualize Src/FAK signaling in live cells with high spatiotemporal resolution, I 
utilized genetically-encoded biosensors based on fluorescence resonance energy transfer 
(FRET)
4, 5
. Compared to traditional biochemical assays, e.g. western blotting and immunostainig, 
FRET-based biosensors can provide accurate real-time information of Src/FAK activation in live 
cells. Furthermore, FRET biosensors can be targeted to different subcellular compartments to 
monitor the local signaling events
6
. This is crucial because the interactions of signaling 
molecules are largely dependent on their subcellular environment due to different sets and 
concentrations of intermediate molecules. Src and FAK can be activated through growth factor 
receptors or integrins at plasma membrane, which contains different microdomains called lipid 
rafts
7
. Thus, Src/FAK biosensors were further targeted into these membrane microdomains by 
lipid modification to detect their activities more accurately. Because the size of lipid rafts is 
beyond the resolution of microscope, these subcellular-targeted Src/FAK biosensors can provide 
powerful tools to study the signaling events at membrane microdomains. 
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In fact, utilizing Src/FAK FRET biosensors targeted at membrane microdomains, I 
discovered the differential Src/FAK activation at microdomains of plasma membrane as 
described in Chapter 3 and 4. The results in Chapter 3 reported the different kinetics of Src 
activation at different microdomains of plasma membrane in response to growth factors and 
pervanadate
4
. Src activation was slower and weaker at lipid rafts, compared to that at non-raft 
regions of plasma membrane. I further found that Src activation at lipid rafts is dependent on 
actin-mediated transportation of Src from perinuclear regions to the plasma membrane, whereas 
Src activation outside lipid rafts is dependent on microtubules. These results indicate that two 
distinct Src populations are differentially regulated via cytoskeleton at different membrane 
compartments. In addition, in Chapter 4, the lipid rafts-targeted FAK biosensor showed much 
stronger FRET response upon both growth factor stimulations and integrin clustering, suggesting 
FAK activation mainly occurs at lipid rafts of plasma membrane
5
. This result also supports the 
idea that lipid rafts provide docking platforms to concentrate FAK molecules and facilitate their 
activation.  
The results in Chapter 4, utilizing lipid rafts-targeted Src/FAK biosensors, also presented 
how Src/FAK activation is regulated in response to different physiological stimulations. Platelet-
derived growth factor (PDGF)-induced FAK activation was mediated and maintained by Src 
kinase activity. In contrast, FAK activation upon integrin clustering was independent of the 
kinase activity of Src, and in fact, FAK kinase activity was required for Src activation. These 
results suggest that the FAK/Src complex is differentially regulated in growth factor- and 
integrin-mediated signaling pathways. This differential signaling hierarchy of the Src/FAK 
complex may contribute to different modes of cellular responses upon different physiological 
stimulations.   
In addition to chemical stimulations, the results in Chapter 5 also showed how FAK 
activity is regulated by mechanical environment. I discovered that the interactions between 
different ECM molecules and specific integrin subtypes can differentially regulate FAK 
activation by mechanical environment. FAK activation on fibronectin (FN) was more dependent 
on surface rigidity than on collagen (CL), because mechanical tension-dependent unfolding of 
FN molecule is required for the activation of integrin 5β18, while CL can directly bind to and 
activate integrin 2β1. These results suggest that outside mechanical signals can be differently 
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translated inside cells through the interactions between specific integrin subtypes and ECM 
molecules.  
In summary, the researches in this thesis can help in-depth understanding on how 
Src/FAK signaling is regulated at microdomains of plasma membrane. The integration of FRET-
based biosensors and subcellular targeting signals can be unique and powerful tools to study 
accurate signaling events at the subcellular level in live cells. In particular, many targeting 
signals are now available, e.g. nucleus, outer plasma membrane, and endoplasmic reticulum
6
, 
thus FRET biosensors with different subcellular targeting signals can be utilized to further study 
various signaling events. This thesis also provides valuable insights on how Src/FAK signaling is 
regulated upon various chemical and mechanical factors. These insights will help us to develop 
effective therapeutic tools to treat diseases such as cancer. 
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